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GENERAL ABSTRACT 
 
The antibacterial potency of the extracts of the seed of Garcinia kola (bitter kola) was investigated in 
this study against a panel of referenced, environmental and clinical bacterial strains. The killing rates 
of the active extract as well as their potential for combination antibacterial therapy with standard 
antibiotics were also elucidated using standard procedures.  
The aqueous and acetone extracts of the seed were screened for activity against 27 bacterial 
isolates. The aqueous extract exhibited activity mainly against Gram positive organisms with 
Minimum inhibitory concentration (MIC) values ranging from 5 mgml-1 – 20 mgml-1, while the acetone 
extract showed activity against both Gram negative and Gram positive organisms with MIC values 
ranging from 10 mgml-1 - 0.156 mgml-1. The acetone extract also showed rapid bactericidal activity 
against Staphylococcus aureus ATCC 6538 with a 3.097 Log10 reduction in counts within 4 hours at 
0.3125 mgml-1 and a 1.582 Log10 reduction against Proteus vulgaris CSIR 0030 at 5 mgml-1 after 1 
hour.   
In addition, the aqueous, methanol and acetone extracts of the seeds also exhibited activity against 
four clinical strains of Staphylococcus isolated from wound sepsis specimens. The MIC values for the 
aqueous extract were 10 mgml-1 for all the isolates while the acetone and methanol extracts had 
lower values ranging from 0.3125 - 0.625 mgml-1. The acetone extract was strongly bactericidal 
against Staphylococcus aureus OKOH3 resulting in a 2.70 Log10 reduction in counts at 1.25 mgml-1 
within 4 hours of exposure and a complete elimination of the organism after 8 hours. The bactericidal 
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activity of the same extract against Staphylococcus aureus OKOH1 was weak, achieving only a 2.92 
Log10 reduction in counts at 1.25 mgml-1 (4× MIC) in 24 hours. 
In the test for interactions between the acetone extract of the seeds and antibiotics, synergistic 
interactions were observed largely against Gram positive organisms using the FIC indices, (indices 
of 0.52 - 0.875) with combinations against Gram negatives yielding largely antagonistic interactions 
(indices of 2.0 to 5.0). Synergy (≥ 1000 times or ≥ 3 Log10 potentiation of the bactericidal activity) 
against both Gram negative and Gram positive organisms was detected by time kill assays mainly 
involving the antibiotics tetracycline, chloramphenicol, amoxycillin and penicillin G. Combinations 
involving erythromycin and ciprofloxacin consistently gave antagonistic or indifferent interactions. 
 
We conclude that the acetone extract of Garcinia kola seeds possess strong bactericidal activities 
against both Gram positive and Gram negative organisms and can be therapeutically useful in the 
treatment of bacterial infections including the problematic staphylococcal wound infections. In 
addition, the acetone extract can be a potential source of broad spectrum resistance modifying 
compounds that can potentially improve the performance of antibiotics in the treatment of drug 
resistant infections.  
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 
Throughout the history of mankind, infectious diseases have remained a major cause of death and 
disability accounting for about 22% of the global disease burden (Murray and Lopez, 1997). Over 
50% of the deaths in children in Sub-Saharan Africa results from infectious causes (Lopez et al., 
2006).  The discovery of penicillin in the 1940s and several other antibiotics in subsequent years led 
to great improvements in the management of infectious diseases particularly in developed countries. 
However, despite this success, the increased use of antibiotics led to the inevitable development of 
resistance, with the effect that diseases that were hitherto thought to have been controlled by 
antibiotics later re-emerged as resistant infections (Norrby et al., 2005). 
At present major pathogenic bacteria that contribute the most to the global infectious disease burden 
such as Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella 
pneumoniae, Pseudomonas aeruginosa, Salmonella species and Mycobacterium tuberculosis are 
resistant to standard antibiotic therapies (Styers et al., 2006; Fluit et al., 2001; Gandhi et al., 2006). 
This global emergence of multi-drug resistant bacterial strains has limited the effectiveness of current 
drugs, causing treatment failures (Hancock, 2005). The containment of this drug resistance requires 
that, new potent antimicrobial compounds be identified as alternatives to existing antibiotics 
(Overbye and Barrett, 2005). However, the current state of development of new antimicrobial drugs 
is not encouraging with only a few new ones being licenced in recent years (Levy and Marshall, 
2004; Norrby et al., 2005). This mismatch between the slow development of new drugs and the fast 
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emergence of resistant strains makes the future management of infectious diseases look bleak. As 
an alternative and perhaps a sustainable option, attempts to improve the efficacy of available 
antibiotics, particularly the older and cheaper ones have been suggested (Lomovskaya and Bostain, 
2006).  
Medicinal plants continue to play a central role in the healthcare systems of large proportions of the 
world’s population, particularly in developing countries, where herbal medicine has a long and 
uninterrupted history of use (Koduru et al., 2007). According to the World Health Organisation 
(WHO), up to 80% of the population in Africa depends on traditional herbal medicine for primary 
health care, accounting for around 20% of the overall drug market (WHO, 2004). The popularity of 
such plants in these communities owes largely to their local availability and price affordability 
(Voravuthikunchai and Kitpipit, 2005) and also confirms their effectiveness.  
Plants produce a wide variety of secondary metabolites many of which have been reported to be of 
therapeutic value. Of the more than 250 000 species of higher plants in the world, only about 5 -10% 
have been chemically investigated (Tshibangu et al., 2001). This raises the prospects of obtaining 
novel chemotherapeutic compounds if this vastly untapped resource could be adequately explored. 
The prospect of obtaining drugs from plants has been demonstrated by some notable examples of 
important pharmaceuticals derived from plant precursors. For instance, the antimalarial drug Quinine 
was derived from the quinoline alkaloid of Cinchona spp.; the topical analgesic Capsaicin was 
derived from a phenylalkyl-amine alkaloid of Capsicum spp; and the antineoplastic agent 
Camptothecina was derived from an indol alkaloid of Camptotheca acuminate (Raskin et al., 2002). 
The rich chemical diversity in plants has also been reported to be a promising source of antibacterial 
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compounds (Bylka et al., 2004; Smith et al., 2007; Machado et al., 2002), raising hopes of obtaining 
novel antibiotics that can aid the fight against drug resistant infections.  
In addition to plants being potential sources of direct antibacterial drugs, research has also shown 
that some secondary metabolites of plants with no intrinsic antimicrobial activity are useful in 
sensitizing bacterial cells to antimicrobial agents (Stermitz et al., 2000; Tegos et al., 2002). These 
compounds are believed to play a role in the plant’s defence against infection by working in synergy 
with intrinsic antimicrobials. It has therefore been suggested recently, that such compounds can 
potentially be used to improve the efficacy of antibiotics against bacterial pathogens. The findings of 
Shibata et al. (2005), Stapleton et al. (2004), Marquez et al. (2005), Oluwatuyi et al. (2004) and 
Smith et al., (2007) have confirmed that indeed plants can be sources of compounds that can 
potentiate the activity of antibiotics against resistant bacterial pathogens. These compounds have 
variably been termed resistance modifying, modulating or reversal agents. 
While the routine practice has been to screen plant extracts for direct antimicrobial compounds, the 
second option of searching for resistance modifying compounds that can improve the efficacy of 
antibiotics when used in combination, appears more attractive as it allows for the recycling of old and 
relatively cheaper antibiotics that have been rendered ineffective due to resistance. 
Description of the Study Plant: Garcinia kola 
Garcinia kola is a tropical tree of the family Guttiferae commonly found in West and Central Africa 
with a geographical distribution extending from Angola, the Democratic Republic of Congo, Congo 
(Brazeville), Gabon, Cameroon, Central Africa Republic, Nigeria, Ghana, Benin, Togo, Ivory Coast, 
Liberia and Sierra Leone (Eyog-Matig et al., 2007). The tree occurs in wet and moist semi deciduous 
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forests as well as in savannah regions where the average water availability is equivalent to 2000 - 
2500 mm of rainfall per annum, temperature ranges of 21 °C to 32 °C and minimum relative humidity 
of 76.34% (Eyog-Matig et al., 2007).   
 
Figure 1: Part of the Garcinia kola plant showing the fruits.  
Picture by P. Latham. Source: http://users.telenet.be/sf16063/pauwels/GarcKola.JPG 
 
Garcinia kola plants grow to about 15 - 17 m tall with a fairly narrow crown. The plants bear fruits in 
about 10 - 12 years of their life cycle. The fruit is a drupe of about 5 - 10 cm in diameter (Figure 1) 
weighing approximately 30 - 50 g. It is usually smooth and contains a yellow-red pulp (Agyili et al., 
2006). Each fruit contains about 1 - 4 oval-shaped seeds of approximately 8 g. The seed coat is 
brown with branched lines (Figure 2), the kernels are pale and penetrated with pockets of resin. The 
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embryo is not well differentiated into cotyledons and embryonic axis, rather most of the seed is a 
mass of undifferentiated tissue (Agyili et al., 2006). 
Garcinia kola is one of the many non-timber forest plants that are of high socio-economic importance 
in West Africa. It is probably the most common source of chew sticks in West Africa. Split stems and 
twigs are used as chewing sticks in many parts of Africa, and have been commercialized in the major 
cities for years, offering natural dental care (Agyili et al., 2006). The seed, commonly known as bitter 
kola, is a masticatory used in traditional hospitality, cultural and social ceremonies (Farombi et al., 
2000). 
 
Figure 2: Garcinia kola seeds  
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The dried and ground seeds are mixed with honey to make a traditional cough mixture (Onunkwo et 
al., 2004). Extracts of the seeds are also used by communities in the treatment of bronchitis and 
throat infections, for the relief of colic, curing of head or chest colds as well as in the treatment of 
liver disorders (Iwu et al., 1999). In recent years, ground seeds have also been used as an industrial 
bittering agent in some Nigerian breweries (Okoro and Aina, 2007). 
Garcinia kola is a plant that has shown tremendous potential as a source of therapeutic compounds. 
The seed has been reported to possess antibacterial, antiviral, anti-inflammatory, antioxidant, 
antidiabetic, as well as antihepatotoxicity potentials (Farombi et al., 2002; Farombi, 2000; Akoachere 
et al., 2002). The tree is therefore one of the prime medicinal plants of the African continent with a 
potential to provide relief to a continent with such a high infectious disease burden. A number of 
compounds with in vitro antibacterial activity have been isolated from the extracts of this plant. These 
include benzophenones such as kolanone and hydroxybiflavononols like GB1 (Madubunyi, 1995; 
Han et al., 2005). The therapeutic activity of the plant has been attributed to flavonoids which are the 
dominant compounds of the plant. These vary from simple flavonoids such as apigenin and fisetin to 
biflavonoids such as amentoflavone and kolaflavonone (Iwu and Igboko, 1982). Some new 
flavonoids still continue to be identified from the plant (Han et al., 2005). 
While the antibacterial activities of the seeds of Garcinia kola have been investigated by other 
researchers, activity has largely been demonstrated for the aqueous, ethanol and petroleum ether 
extracts. This limited extractant variability is likely to underestimate the antibacterial potential of the 
plant. The quantity and diversity of extracted compounds has been shown to depend on the 
extracting solvent, with acetone and methanol (Eloff, 1998) having been observed to efficient 
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extractants. Often the minimum inhibitory concentrations (MICs) are used as the only tool for 
predicting the antimicrobial efficacy of the plant. There are limitations to the use of such data alone, 
mainly that it does not take into account the time related antimicrobial effects (Kiem and Schentag, 
2006). It is also likely therefore that the antibacterial potentials of the plant could have been 
underestimated.  In addition, the bactericidal efficacy of the extracts of this plant in terms of death 
kinetics has not been reported, yet this is a fundamental tool for determining the potency of any 
potential antimicrobial substance. Furthermore, recent research on the therapeutic potentials of 
medicinal plants has shown that in addition to them being sources of direct antimicrobial compounds, 
they can also be sources of compounds that can improve the performance of antibiotics when used 
in combination including in a number of cases against resistant pathogens (Gibbons, 2004). While 
the extracts of Garcinia kola seeds have been investigated for their antimicrobial activities, their 
interactions with antibiotics have also not been reported. 
This research therefore aimed to contribute to the already existing knowledge about the therapeutic 
potentials of Garcinia kola, by investigating the antibacterial and resistance modifying activities of 
seed extracts of this plant. Specifically the research had the following objectives; 
• to investigate the antibacterial activity of extracts of Garcinia kola seeds against a wide range 
of bacterial isolates, representing pathogenic microbes; 
• to determine the Minimum Inhibitory Concentrations (MICs) of the extracts as a prediction 
index for the therapeutic potentials of the plant; 
• to determine the bactericidal activity of the extracts by measurement of the rate of kill as  an 
alternative prediction tool for the therapeutic potentials of the plant; 
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• to investigate the effect of combinations between extracts of the plant and antibiotics on the 
susceptibility of bacterial isolates; and  
• to investigate the activity of the extracts of the plant against clinical strains of Staphylococcus 
isolated from cases of wound sepsis. 
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CHAPTER 2 
The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of 
antimicrobial and resistance modifying agents 
ABSTRACT 
The problem of antibiotic resistance, which has limited the use of cheap and old antibiotics, has 
necessitated the need for a continued search for new antimicrobial compounds. Understanding the 
mechanisms of resistance is important in the development of strategies to solving the problem. 
Active efflux of drugs, alteration of target sites and enzymatic degradations are the strategies by 
which pathogenic bacteria acquire or develop intrinsic resistance to antibiotics. Multidrug resistance 
(MDR) pumps capable of recognizing and expelling a variety of structurally unrelated compounds 
from the bacterial cell conferring resistance to a wide range of antibiotics have since been 
chracterised in many Gram positive and Gram negative pathogens like Staphylococcus aureus, 
Pseudomonas aeruginosa, Escherichia coli and, more recently, in mycobacteria. The ability of some 
chemical compounds (called MDR inhibitors or resistance modifying agents) to modify the resistance 
phenotype in bacteria by working synergistically with antibiotics in vitro has since been observed. 
The search for such compounds which can be combined with antibiotics in the treatment of drug 
resistant infections may be an alternative to overcoming the problem of resistance in bacteria. Crude 
extracts of medicinal plants stand out as veritable sources of potential resistance modifying agents 
and the African biosphere promises to be a potential source of such compounds owing to its rich 
plant species diversity.  
Key words: Antibiotic resistance, resistance modifying agents, plant extracts. 
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INTRODUCTION 
Since the discovery of antibiotics and their uses as chemotherapeutic agents, there was a belief in 
the medical fraternity that this would lead to the eradication of infectious diseases. However diseases 
and disease agents that were once thought to have been controlled by antibiotics are returning in 
new forms resistant to antibiotic therapies (Levy and Marshall, 2004). Incidents of epidemics due to 
such drug resistant microorganisms are now a common global problem posing enormous public 
health concerns (Iwu et al., 1999). The global emergence of multi-drug resistant bacterial strains is 
increasingly limiting the effectiveness of current drugs and significantly causing treatment failure of 
infections (Hancock, 2005). Examples include methicillin-resistant staphylococci and pneumococci 
that are resistant to penicillin and macrolides; vancomycin-resistant enterococci as well as multidrug-
resistant Gram negative organisms (Norrby et al., 2005).  
As resistance to old antibiotics spreads, the development of new antimicrobial agents has to be 
expedited if the problem is to be curtailed. However, the past record of rapid, widespread and 
emergence of resistance to newly introduced antimicrobial agents indicates that even new families of 
antimicrobial agents will have a short life expectancy (Coates et al., 2002).  
Confronted with a possible shortage of new antimicrobials, there is need to ensure a careful use of 
our available drugs. This has led to calls for controlled use of antibiotics through the reduction of 
dosage used per regime of treatment or by regulating prescriptions in areas such as animal 
husbandry and aquaculture (Hernandez, 2005). While reduced use could lead to delayed resistance 
development, the emergence of resistant strains is from an evolutionary viewpoint inevitable. It 
becomes imperative therefore that alternative approaches are explored. Targeting and blocking 
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resistance processes could be an attractive approach. The presence of efflux pumps and multidrug 
resistance (MDR) proteins in antibiotic resistant organisms contribute significantly to the intrinsic and 
acquired resistance in these pathogens. The discovery and development of new compounds that 
either block or circumvent resistance mechanisms could improve the containment, treatment, and 
eradication of these strains (Oluwatuyi et al., 2004). A few studies such as Gibbons et al. (2003), 
Dickson et al. (2006) and Braga et al. (2005) have reported that plant extracts can enhance the in 
vitro activity of certain antibiotics against strains of MDR Staphylococcus aureus and other 
pathogens. These studies have prompted the search for such MDR Pump or Efflux Pump inhibitors 
from medicinal plants. This paper reviews the mechanisms of resistance to antibiotic by pathogenic 
bacteria and how such processes can be curtailed by the use of plant extracts and plant derived 
compounds in a bid to highlight the importance of this untapped resource in the fight against the 
spread of antibiotic resistant pathogens.     
 
THE CHALLENGE OF ANTIBIOTIC RESISTANCE 
The development of resistance in bacteria is one of the mechanisms of natural adaptation to the 
presence of an antimicrobial agent that inhibits susceptible organisms and selects for the resistant 
ones. Under continued selection pressure, the selected resistant organisms multiply and spread to 
other geographic locations as well as to other microbes by transfer of resistance genes (Levy and 
Marshall, 2004). Selection of resistant strains occurs so rapid for some bacteria that clinical 
usefulness of the antibiotics is lost within a 5-year period (Bush, 2004).  
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The emergence and spread of microbes that are resistant to cheap and effective first-choice drugs 
has become a common occurrence. The problem is even more evident in bacterial infections which 
contribute most to the global infectious disease burden such as diarrheal, respiratory tract, 
meningitis, sexually transmitted infections, and tuberculosis (WHO, 2002).   Resistance to penicillin 
in Staphylococcus aureus first appeared in 1942 immediately following its clinical use. By the late 
1960s, more than 80% of both community- and hospital-acquired staphylococcal isolates were 
resistant to penicillin (Lowy, 2003). At present most clinical isolates of Staphylococcus aureus are 
multiple-drug resistant (resistant to three or more of agents such as ciprofloxacin, erythromycin, 
clindamycin, gentamycin, trimethoprim/sulphamethoxazole, linezolid, and vancomycin) (Styers et al., 
2006). Global resistance rates in Streptococcus pyogenes isolates are as high as 80% for 
erythromycin and 50% for penicillins (Low, 2005). Recently, strains of Mycobacterium tuberculosis 
that are resistant to virtually all classes of drugs currently available for the treatment of TB (isoniazid, 
rifampicin, fluoroquinolones, aminoglycosides (amikacin, kanamycin and capreomycin)) have been 
identified in the KwaZulu Natal Province of South Africa (Gandhi et al., 2006) earning a new 
classification termed, Extremely Drug Resistant Tuberculosis (XDR TB).  
When infections become resistant to first-choice or first-line antimicrobials, treatment has to be 
switched to second- or third-line drugs, which are nearly always expensive. In many poor countries, 
the high cost of such replacement drugs is prohibitive, with the result that some diseases can no 
longer be treated in areas where resistance to first-line drugs is widespread (WHO, 2002). Faced 
with such a challenge, there is need to develop alternative approaches in addition to the search for 
new antimicrobial compounds. Such approaches might include strategies that target resistance 
mechanisms coupled with antibiotics.   
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 MECHANISMS OF ANTIBIOTIC RESISTANCE IN PATHOGENIC BACTERIA 
Resistance to antimicrobials is as a result of three main strategies namely enzymatic inactivation of 
the drug (Davies, 1994), modification of target sites (Spratt, 1994) and extrusion by efflux (Nikaido, 
1994). While chemical modifications could be significant in antibiotic resistance, exclusion from the 
cell of unaltered antibiotic represents the primary strategy in denying the antibiotic, access to its 
targets and this is believed to enhance resistance even in cases where modification is the main 
mechanism (Li et al., 1994b).   
Alteration of target sites  
Chemical modifications in the antibiotic target may result in reduced affinity of the antibiotic to its 
binding site (Lambert, 2005). This is a mechanism employed by a number of pathogenic bacteria in 
evading the effect of antibiotics. Modifications are usually mediated by constitutive and inducible 
enzymes. Resistance to macrolides, lincosamide and streptogramin B antibiotics (MLSB resistance) 
in pathogenic Streptococcus species is a result of methylation of the N6 amino group of an adenine 
residue in 23S rRNA. This is presumed to cause conformational changes in the ribosome leading to 
reduced binding affinity of these antibiotics to their binding sites in the 50S ribosomal subunit 
(Seppala et al., 1998; Kataja et al., 1998). Beta-lactams antibiotics function by binding to and 
inhibiting the biosynthetic activity of Penicillin Binding Proteins (PBPs), thereby blocking cell wall 
synthesis. In Staphylococcus aureus and Streptococcus pneumoniae, resistance to beta-lactams can 
be a result of mutations leading to the production of PBP2a and PBP2b respectively. The two 
proteins have a reduced affinity for beta-lactams and yet they take over the functions of normal PBPs 
in the presence of inhibitory levels of beta-lactams (Golemi-Kotra et al., 2003; Grebe and 
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Hakenbeck, 1996). This mechanism of resistance is also responsible for beta-lactam resistance in 
non- beta-lactamase producing Haemophillus influenzae (Matic et al., 2003).  
Enzymatic inactivation  
The production of hydrolytic enzymes and group transferases is a strategy employed by a number of 
pathogens in evading the effect of antibiotics (Wright, 2005). Genes that code for antibiotic degrading 
enzymes are often carried on plasmids and other mobile genetic elements. The resistance to beta-
lactam antibiotics by both Gram negative and Gram positive bacteria has long been attributed to 
beta-lactamases (Frere, 1995). These enzymes confer significant antibiotic resistance to their 
bacterial hosts by hydrolysis of the amide bond of the four-membered beta-lactam ring (Wilke et al., 
2005). Resistance to aminoglycosides in Gram negative bacteria is most often mediated by a variety 
of enzymes that modify the antibiotic molecule by acetylation, adenylation or phosphorylation (Over 
et al., 2001). 
Antibiotic efflux  
It is now widely recognized that constitutive expression of efflux pump proteins encoded by house-
keeping genes that are widespread in bacterial genomes are largely responsible for the phenomenon 
of intrinsic antibiotic resistance (Lomovskaya and Bostian, 2006). Several studies have shown that 
active efflux can be a mechanism of resistance for almost all antibiotics (Li et al. 1994a; Gill et al. 
1999 and Lin et al. 2002). The majority of the efflux systems in bacteria are non-drug-specific 
proteins that can recognize and pump out a broad range of chemically and structurally unrelated 
compounds from bacteria in an energy-dependent manner, without drug alteration or degradation 
(Kumar and Schweizer, 2005). The consequence of this drug extrusion is that, it leads to a reduced 
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intracellular concentration of the antimicrobial such that the bacterium can survive under conditions 
of elevated antimicrobial concentration (Marquez, 2005). The MIC of the drug against such 
organisms will be higher than predicted. 
Multidrug resistance efflux pumps are ubiquitous proteins present in both Gram positive and Gram 
negative bacteria as either chromosomally encoded or plasmid encoded (Akama et al., 2005). 
Although, such proteins are present constitutively in bacteria, the continued presence of the 
substrate induces over-expression (Teran et al., 2003). This increased transcription is responsible for 
the acquired resistance.  In Gram negative bacteria, the effect of the efflux pumps in combination 
with the reduced drug uptake due to the double membrane barrier is responsible for the high inherent 
and acquired antibiotic resistance often associated with this group of organisms (Lomovskaya and 
Bostian, 2006).  
Efflux transporters constitute about 6% to 18% of all transporters found in any given bacterial cell 
(Paulsen et al., 1998). Currently, much attention is being paid towards understanding the operating 
mechanisms of these pumps. This has potential applications in the design of transport inhibitors that 
could be used in combination with antibiotics in development of clinically useful drugs (McKeegan et 
al., 2004). 
The MDR pumps of pathogenic bacteria known so far, belong to five families of transporters namely; 
the major facilitator superfamily (MFS), the adenosine triphosphate (ATP)-binding cassette (ABC) 
superfamily, the small multidrug resistance (SMR) family and the resistance-nodulation-cell division 
(RND) superfamily and the multidrug and toxic compound extrusion (MATE) family (Kumar and 
Schweizer, 2005).  
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Some characterized Efflux proteins of pathogenic bacteria 
The NorA protein of Staphylococcus aureus is the best studied chromosomally encoded pump in 
pathogenic Gram positive bacteria (Hooper, 2005). It is present in Staphylococcus epidermidis but 
appears to be absent in Enterococcus faecalis or in Gram negative organisms, such as E. coli and K 
pneumoniae (Kaatz et al., 1993). Overexpression of the NorA gene in Staphylococcus aureus 
confers resistance to chloramphenicol and hydrophilic fluoroquinolone antimicrobials (Hooper, 2005; 
Kaatz and Seo, 1995).  
QacA is a member of the major facilitator superfamily of transport proteins, which are involved in the 
uniport, symport, and antiport of a wide range of substances across the cell membrane (Mitchell et 
al., 1998). The QacA multidrug exporter from Staphylococcus aureus mediates resistance to a wide 
array of monovalent or divalent cationic, lipophilic, antimicrobial compounds. QacA provides 
resistance to these various compounds via a proton motive force-dependent antiport mechanism 
(Brown and Skurray, 2001). 
The mefA efflux protein of Streptococcus pyogenes is a hydrophobic 44.2-kDa transposon encoded 
protein, of the Major Facilitator superfamily that mediates efflux of macrolides (Kohler et al., 1999) 
resulting in the M phenotype in Streptococcus pyogenes (Sutcliffe et al., 1996). It shares a 90% 
amino acid homology with MefE (Roberts et al., 1999) of Streptococcus pneumoniae that also 
mediates the efflux of macrolides.  
PmrA (pneumococcal multidrug resistance protein) efflux of Streptococcus pneumoniae is a 
chromosomally encoded protein of the Major facilitator family that confers a resistance profile in 
Streptococcus pneumoniae similar to that of NorA in Staphylococcus aureus (Kohler et al., 1999). 
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The efflux protein which is not expressed constitutively in pneumococcal strains is responsible for 
low-level fluoroquinolone resistance in pneumococci (Kohler et al., 1999; Gill et al., 1999). 
AcrAB-TolC pump is a member of the Resistance-Nodulation-cell division (RND) family of tripartite 
multidrug efflux pumps ubiquitous throughout Gram negative bacteria. In Escherichia coli, the 
multidrug efflux pump has been shown to expel a wide range of antibacterial agents (Touze et al., 
2004). The resistance to fluoroquinolones, chloramphenicol-florfenicol and tetracycline in the food 
borne pathogen Salmonella enterica serovar Typhimurium definitive phage type 104 is highly 
dependent on the presence of AcrAB-TolC efflux pump (Baucheron et al., 2004). The tripartite pump 
is also the major efflux mechanism of the nosocomial pathogen Enterobacter aerogenes (Masi et al., 
2003; Pradel and Pages, 2002). The pump has also been associated with baseline level resistance 
of Haemophillus influenzae Rd to erythromycin, rifampin, novobiocin, and dyes such as ethidium 
bromide and crystal violet (Sanchez et al., 1997). 
The RND family efflux pump, MexAB-OprM, of the opportunistic pathogen, Pseudomonas aeruginosa 
has been extensively characterized. Like other tripartite efflux proteins, it consists of three membrane 
bound subunits, MexA, MexB, and OprM, anchoring the inner and outer membranes. The MexB 
subunit is central to the pump function, which spans the cytoplasmic membrane 12 times, it selects 
antibiotics to be exported, and is assumed to transport the substrates expending the energy of the 
proton gradient across the cytoplasmic membrane (Akama et al., 2004). Resistance to beta-lactams 
and non-beta-lactam antibiotics such as quinolones, tetracyclines, and trimethoprim has been 
attributed to efflux by the MexAB-OprM pump (Ziha-Zarifi et al., 1999). Other Mex efflux proteins 
namely mexCD, mexEF MexXY mediating multidrug resistance have also been cloned from the 
chromosome of Pseudomonas aeruginosa (Mine et al., 1999). 
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THE USE OF RESISTANCE MODIFYING AGENTS IN COMBINATION WITH ANTIBIOTICS TO 
OVERCOME RESISTANCE 
The selection pressure exerted by the continued presence of bactericidal or bacteriostatic agents 
facilitates the emergence and dissemination of antibiotic resistance genes. Over generations, the 
genotypic makeup of bacterial populations is altered (Taylor et al., 2002). The clinical implications of 
this are that many infections become untreatable resulting in serious morbidity and mortality. 
Although the introduction of new compounds into clinical use has helped to curtail the spread of 
resistant pathogens, resistance to such new drugs, has developed in some cases. For instance, 
resistance to the lipopeptide, daptomycin among clinical isolates of Enterococcus faecium has 
already been detected (Pankey et al. 2005). This is despite the fact that the drug was first licensed in 
2003 (Norrby et al., 2005).  
It has been observed by several studies that antibiotic combinations can have synergistic benefits 
and interactions between existing antibiotics (Bayer et al., 1980; Hooton et al., 1984; Cottagnoud et 
al., 2000; Hallander et al., 1982). Several current therapeutic regimes are based on synergistic 
interactions between antibiotics with different target sites. As new antimicrobial compounds are 
discovered, there is need to assess their potentials in combination therapies with old antibiotics that 
have been rendered ineffective by the development of resistant strains, even when such compounds 
are not directly evidently inhibitory. Taylor et al. (2002) suggested that the use of agents that do not 
kill pathogenic bacteria but modify them to produce a phenotype that is susceptible to the antibiotic 
could be an alternative approach to the treatment of infectious disease. Such agents could render 
the pathogen susceptible to a previously ineffective antibiotic, and because the modifying agent 
applies little or no direct selective pressure, this concept could slow down or prevent the emergence 
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of resistant genotypes. The inhibition of resistance expression approach was successfully used in the 
production of Augmentin, a combination of amoxycillin and clavulanic acid (Reading and Cole, 1977). 
In this case, clavulanic acid is an inhibitor of class-A beta-lactamases which is co-administered with 
amoxicillin. The combination has been used clinically since the late 1970s (Neu et al., 1993). A 
similar approach can be used for target-modifying enzymes and for efflux systems.  
A number of in vitro studies have reported the use of plant extracts in combination with antibiotics, 
with significant reduction in the MICs of the antibiotics against some resistant strains (Al-hebshi et 
al., 2006; Darwish et al., 2002; Betoni et al., 2006). The curative effect of plant extracts in this 
combination study has been variably referred to as resistance modifying/modulating activity 
(Gibbons, 2004). This ability of plant extracts to potentiate antibiotics has not been well explained. It 
is speculated that inhibition of drug efflux, and alternative mechanisms of action could be responsible 
for the synergistic interactions between plant extracts and antibiotics (Lewis and Ausubel, 2006; 
Zhao et al., 2001).  
Efflux pump inhibition in combination with antibiotics as a strategy for overcoming resistance  
The discovery and development of clinically useful Efflux Pump Inhibitors (EPIs) that decrease the 
effectiveness of efflux pumps represents a significant advance in the development of therapeutic 
regimes for the treatment of MDR-related conditions. This approach termed the EPI strategy 
(Lomovskaya and Bostian, 2006), is based on blocking the activity of the pumps, resulting in the 
accumulation of the antibiotic inside the bacterial cell, consequently increasing access to its target 
sites. In addition, this will lead to increased susceptibility of the bacterium, thus implying that the 
therapeutic effect of the drug is achieved with low concentrations. Combining broad spectrum efflux 
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pump inhibitors with current drugs that are pump substrates can recover clinically relevant activity of 
those compounds and thus may provide new dimensions to the ever increasing need for 
development of new antimicrobial agents (Kaatz, 2002). This approach will in addition lead to the 
preservation and improvement of the usefulness of old and cheap antibacterial agents. Ultimately 
this could reduce the appearance and spread of resistant mutants (Kaatz, 2002). 
Multiple targets and mutual interference strategies  
A combination of antimicrobials with different target sites and mechanisms of action can be beneficial 
in reducing resistance development. The likelihood that a pathogen could simultaneously develop 
resistance against more than one drug is low (Dryselius et al., 2005). Other combinations may 
involve antibiotics and other compounds that are not antimicrobial but can enhance the activity of the 
antibiotics. Combinations between antibiotics and known or new antimicrobial compounds might 
uncover some beneficial potential that might be useful in curbing resistance to antibiotics.     
Some drug formulations in current use are already based on the concept of dual targets or mutual 
interference (Rossolini and Mantengoli, 2005). For instance, the combination of trimethoprim and 
sulphamethoxazole, (co-trimoxazole) involves a mutual interference of two sequential steps in the 
bacterial folate biosynthesis pathway. Sulphamethoxazole competitively inhibits bacterial 
dihydropteroate synthetase, an enzyme involved in the first step in the reaction leading to folic acid 
synthesis. Trimethoprim inhibits the enzyme dihydrofolate reductase, involved in the next step in the 
folic acid pathway (Jerry and Smilack, 1999). Beta-lactamase inhibitors, clavulanic acid and 
sulbactam have been used to enhance the activity of beta lactam antibiotics against beta lactamase 
producing organisms (Moosdeen et al., 1988; Maddux, 1991).  
26 
 
The synergy between epigallocatechin gallate (EGCg) in tea catechins (the main compounds 
responsible for the antimicrobial activity of tea) and oxacillin observed by Zhao et al., (2001) was 
attributed to the combined action of EGCg and Oxacillin on the biosynthesis of the cell wall thereby 
bypassing the resistance mechanism resulting from the reduced affinity of Penicillin Binding Proteins 
(PBP) to Oxacillin.  
 
PLANTS AS SOURCES OF NEW ANTIMICROBIALS AND RESISTANCE MODIFYING AGENTS 
Plants have traditionally provided a source of hope for novel drug compounds, as plant herbal 
mixtures have made large contributions to human health and well-being (Iwu et al., 1999). Owing to 
their popular use as remedies for many infectious diseases, searches for substances with 
antimicrobial activity in plants are frequent (Betoni et al., 2006; Shibata et al., 2005). Plants are rich 
in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, 
which have been found in vitro to have antimicrobial properties (Lewis and Ausubel, 2006; Cowan, 
1999). Examples of some of these compounds are shown in Table 1. Literature is awash with 
compounds that have been isolated from a variety of medicinal plants. Despite this abundant 
literature on the antimicrobial properties of plant extracts, none of the plant derived chemicals have 
successfully been exploited for clinical use as antibiotics (Gibbons, 2004). 
A significant part of the chemical diversity produced by plants is thought to protect plants against 
microbial pathogens. Gibbons (2004), observes that a number of plant compounds often classified as 
antimicrobial produce MIC ranges greater than 1000 µgml-1 which are of no relevance from a clinical 
perspective. Tegos et al. (2002), suggests that a vast majority of plant compounds showing little in 
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vitro antibacterial activity are not antimicrobial but are regulatory compounds playing an indirect role 
in the plant defence against microbial infections.  
The observation that plant derived compounds are generally weak compared to bacterial or fungal 
produced antibiotics and that these compounds often show considerable activity against Gram 
positive bacteria than Gram negative species has been made by many (Nostro et al., 2000; Gibbons, 
2004). This led to Tegos et al. (2002) hypothesizing that; Plants produce compounds that can be 
effective antimicrobials if they find their way into the cell of the pathogen especially across the double 
membrane barrier of Gram negative bacteria. Production of efflux pump inhibitors by the plant would 
be one way to ensure delivery of the antimicrobial compound. This hypothesis has been supported 
by the findings of Stermitz et al., (2000a,b), who observed that Berberis plants which produce the 
antimicrobial compound, berberine, also make the MDR inhibitors 5-methoxyhydnocarpin D (5-MHC-
D) and pheophorbide A. The MDR inhibitors facilitated the penetration of berberine into a model 
Gram positive bacterium, Staphylococcus aureus. In testing their hypothesis, Tegos et al. (2002), 
showed that two MDR inhibitors (INF271 and MC207110) dramatically increased the effectiveness of 
thirteen putative plant antimicrobial compounds against Gram negative and Gram positive bacteria 
including isolates known to express efflux pumps.  
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Table 1: Examples of some plant derived compounds with antimicrobial properties 
Class of Compound Examples Plant sources Reference 
Coumarins and their 
derivatives 
asphodelin A 4'-O-β-D-
glucoside 
asphodelin A 
Asphodelus microcarpus 
 
El-Seedi (2007) 
Epicatechin  
 
Calophyllum brasiliense Pretto et al. (2004) Simple phenols 
Epigallocatechin 
Epigallocatechin gallate 
Epicatechin gallate 
 
Camellia sinensis Mabe et al. (1999) 
Hamilton-Miller (1995) 
Flavonoids 
 
 Isocytisoside 
 
Eucalyptin 
Aquilegia vulgaris L. 
 
Eucalyptus maculate 
 
Bylka et al. (2004) 
 
Takahashi et al. (2004) 
 
flavones  luteolin 
 
GB1(hydroxybiflavononol) 
Senna petersiana 
 
Garcinia kola 
Tshikalange et al. (2005) 
 
Madubunyi (1995),  
Han et al. (2005) 
Tannins Ellagitannin Punica granatum 
 
Machado et al. (2002) 
Alkaloids Berberine Mahonia aquifolium Cernakova and 
Kostalova (2002) 
Ferruginol, (Diterpene) 
Epipisiferol (Diterpene) 
 
Chamaecyparis lawsoniana 
 
 
Smith et al. (2007) 
 
 
Terpenes 
1-Oxoferruginol Salvia viridis Ulubelen et al. (2000) 
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These studies have provided the basis for understanding the action of plant antimicrobials, namely 
that vast majority of such compounds are agents with weak or narrow-spectrum activities that act in 
synergy with intrinsically produced efflux pump inhibitors. There is reason therefore to believe that, 
plants could be a source of compounds that can increase the sensitivity of bacterial cells to 
antibiotics. Such compounds could be useful particularly against antibiotic resistant strains of 
pathogenic bacteria. The rich chemical diversity in plants promises to be a potential source of 
antibiotic resistance modifying compounds and has yet to be adequately explored.    
 
RESISTANCE MODIFYING ACTIVITIES OF PLANT CRUDE EXTRACTS: THE BASIS FOR 
ISOLATION OF POTENTIALLY USEFUL COMPOUNDS 
 If the isolation of resistance modifying compounds from plants is to be realistic, screening for such 
activities in crude extracts is the first step in identifying leads for isolation of such compounds, and 
some plants have provided good indications of these potentials for use in combination with 
antimicrobial therapy. Typical examples are as follows: 
Aqueous extracts of tea (Camellia sinensis) have been shown to reverse methicillin resistance in 
MRSA and also, to some extent, penicillin resistance in beta-lactamase-producing Staphylococcus 
aureus (Stapleton et al., 2004).  Forty to one hundred fold dilutions of tea extracts was able to reduce 
the MICs of high- level resistant MRSA (≥ 256 µgml-1) to less than 0.12 µgml-1 for methicillin and 
penicillin (Yam et al., 1998; Stapleton et al., 2004). Aqueous crude khat (Catha edulis) extracts of 
Yemen showed varying antibacterial activities with a range of 5 - 20 mgml-1 against periodontal 
bacteria when tested in isolation. Addition of the extracts at a sub- MIC (5 mgml-1) resulted in a 2 to 
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4-fold potentiation of tetracycline against resistant strains Streptococcus sanguis TH-13, 
Streptococcus oralis SH-2, and Fusobacterium nucleatum (Al-hebshi et al., 2006). Betoni et al. 
(2006), observed synergistic interactions between extracts of guaco (Mikania glomerata), guava 
(Psidium guajava), clove (Syzygium aromaticum), garlic (Allium sativum), lemongrass (Cymbopogon 
citratus), ginger (Zingiber officinale), carqueja (Baccharis trimera), and mint (Mentha pieria) from 
Brazil  and some antibiotics which represented inhibitors of protein synthesis, cell wall synthesis, 
nucleic acid synthesis and folic acid synthesis against Staphylococcus aureus. Darwish et al. (2002), 
reported that sub-inhibitory levels (200 µgml−1) of methanolic extracts of some Jordanian plants 
showed synergistic interactions in combination with chloramphenicol, gentamycin, erythromycin and 
penicillin G against resistant and sensitive Staphylococcus aureus. The methanolic extract of Punica 
granatum (PGME) showed synergistic interactions with chloramphenicol, gentamycin, ampicillin, 
tetracycline, and oxacillin. The bactericidal activity of the combination of PGME (0.1 × MIC) with 
ampicillin (0.5 × MIC) by time-kill assays, reduced cell viability by 99.9% and 72.5% in MSSA and 
MRSA populations, respectively (Braga et al., 2005). The ethanol extracts of the Chinese plants, 
Isatis tinctoria and Scutellaria baicalensis in combination with ciprofloxacin had synergistic activities 
against antibiotic resistant Staphylococcus aureus (Yang et al., 2005). The combinations of penicillin 
with ethanolic extracts of Paederia scandens and Taraxacun monlicum showed a strong bactericidal 
activity on two strains of Staphylococcus aureus (Yang et al., 2005). When ciprofloxacin was 
incorporated at sub-inhibitory concentrations (1/8 × MIC) to the crude chloroform extracts of Jatropha 
elliptica and the mixture assayed against NorA expressing Staphylococcus aureus, the activity of the 
extract was enhanced. This suggests the presence of an inhibitor of the pump which could restore 
the activity of ciprofloxacin (Marquez et al., 2005). In another study, Ahmad and Aqil (2007) observed 
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that crude extracts of Indian medicinal plants, Acorus calamus, Hemidesmus indicus, Holarrhena 
antidysenterica and Plumbago zeylanica showed synergistic interactions with tetracycline and 
ciprofloxacin against Extended Spectrum beta-lactamase (ESβL), producing multidrug-resistant 
enteric bacteria with ciprofloxacin showing more synergy with the extracts than tetracycline. 
Plant compounds with resistance modifying activities 
Some isolated pure compounds of plant origin have been reported to have resistance modifying 
activities in vitro. Examples of some of the compounds are given in Table 2. This has prompted the 
search for such compounds from a variety of medicinal plants. Some of the compounds which have 
been observed to have direct antimicrobial activity have also been shown to potentiate the activity of 
antibiotics when used at below MIC levels. 
 
 
 
 
 
 
 
 
32 
 
Table 2: Some antibiotic resistance modifying compounds from plants.  
Compound Plant Source Antibiotics 
Potentiated 
Reference 
Ferruginol 
 
5-Epipisiferol 
Chamaecyparis lawsoniana Oxacillin  
Tetracycline  
Norfloxacin 
Tetracycline 
Smith et al. (2007) 
2,6-dimethyl-4-phenyl-
pyridine-3,5-dicarboxylic 
acid diethyl ester 
Jatropha elliptica Ciprofloxacin  
Norfloxacin  
Pefloxacin 
 
Marquez et al. (2005) 
Carnosic acid carnosol Rosmarinus officinalis Erythromycin Oluwatuyi et al. (2004) 
Ethyl gallate Caesalpinia spinosa Beta-lactams Shibata et al. (2005) 
Methyl-1-α-acetoxy-7-α-
14-α-dihydroxy-8,15-
isopimaradien-18-oate  
Methyl-1-α-14-α-
diacetoxy-7-α-hydroxy-
8,15-isopimaradien-18-
oate 
Lycopus europaeus Tetracycline 
Erythromycin 
Gibbons et al. (2003) 
Epicatechin gallate  
Epigallocatechin gallate 
Camellia sinensis Norfloxacin 
Imipenem 
Panipenem 
Beta-lactams 
Gibbons et al. (2004) 
Hu et al. (2002) 
Zhao et al. (2001) 
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The antimicrobial properties of tea (Camellia sinensis) have been found to be a result of the 
presence of polyphenols (Yam et al., 1998; Stapleton et al., 2004; Si et al., 2006). Bioassay directed 
fractionation of the extracts revealed that epicatechin gallate (ECG), epigallocatechin gallate 
(EGCG), epicatechin (EC), and caffeine (CN) are the bioactive components. ECG and CG reduced 
MIC values for oxacillin from 256 and 512 to 1 and 4 mgl-1 against MRSA (Shibata et al., 2005). Ethyl 
gallate, a conginer of alkyl gallates purified from a dried pod of Tara (Caesalpinia spinosa) native to 
South America, intensified beta-lactam susceptibility in MRSA and MSSA strains (Shibata et al., 
2005). The abietane diterpenes, (carnosic acid carnosol) isolated from the aerial parts of Rosmarinus 
officinalis by fractionation of the chloroform extract at 10 µgml-1, potentiated the activity of 
erythromycin (16-32 fold) against strains of Staphylococcus aureus that express the two efflux 
proteins MsrA and TetK. Additionally, carnosic acid was shown to inhibit ethidium bromide efflux in a 
NorA expressing Staphylococcus aureus strain (Oluwatuyi et al., 2004). A penta-substituted pyridine, 
2, 6-dimethyl-4-phenylpyridine-3, 5-dicarboxylic acid diethyl ester and proparcine have been isolated 
from an ethanol extract of rhizome of Jatropha elliptica by bioassay guided fractionation. The pyridine 
at a concentration of 75 µgml-1 was shown to increase by 4-fold, the activity of ciprofloxacin and 
norfloxacin against NorA expressing Staphylococcus aureus when tested at sub-inhibitory 
concentrations (Marquez et al., 2005). Smith et al. (2007), screened active compounds from the 
cones of Chamaecyparis lawsoniana for resistance modifying activities and observed that Ferruginol 
and 5-Epipisiferol were effective in increasing the efficacy of tetracycline, norfloxacin, erythromycin 
and oxacillin against resistant Staphylococcus aureus. The majority of researches on the 
combinations between plant extracts and antibiotics have been focused on the identification and 
isolation of potential resistance modifiers from such natural sources which are considered to be 
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positive results. However, it is likely that such combinations could produce antagonistic interactions 
that most studies have considered irrelevant and therefore ignored.  
 
FUTURE DIRECTIONS 
While there is an abundance of published data validating the antimicrobial activity of medicinal plants 
commonly used in folk medicine, this has not resulted in the identification of commercially exploitable 
plant derived antibacterial agents (Lewis and Ausubel, 2006). The majority of plant derived 
antimicrobial compounds generally have higher MICs than bacterial or fungal produced antibiotics, 
thus limiting their therapeutic potential (Gibbons, 2004). The findings of Tegos et al. (2002) have 
provided a foundation for a rationale on the potential actions of plant derived antimicrobial 
compounds and other compounds with no intrinsic antimicrobial value. It has already been 
established that crude extracts of some medicinal plants and some pure compounds from such 
plants can potentiate the activity of antibiotics in vitro (Marquez et al., 2005; Smith et al., 2007). This 
search for antibiotic resistance modulators in plants represents a new dimension to addressing the 
problem of antibiotic resistance. The chemical diversity available in plants still remains largely 
uninvestigated for potentials in improving the clinical efficacy of antibiotics. Most interestingly are 
medicinal plants and food plants which are inadvertently used with antibiotics in common community 
practices providing opportunities for interactions. As many medicinal plants still remain unexplored, 
there are enormous opportunities for the discovery of novel resistance modifying compounds of plant 
origins. Screening of antibiotic resistance modifying compounds from plants sources are expected to 
provide the basis for identifying leads for the isolation of therapeutically useful compounds. This 
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could in future be followed by in vivo assessments to determine the clinical relevance of such 
compounds. This represents a potential area of future investigation.  
  
 CONCLUSION 
The quest for solutions to the global problem of antibiotic resistance in pathogenic bacteria has often 
focused on the isolation and characterization of new antimicrobial compounds from a variety of 
sources including medicinal plants. This has seen several medicinal plants being screened for 
antimicrobial activities. Investigations into the mechanisms of bacterial resistance have revealed that 
active efflux plays a significant role in the development of bacterial acquired and intrinsic resistance. 
Overcoming efflux has therefore been seen as an attractive alternative to circumventing the problem. 
Bacterial efflux pump inhibitors have since been isolated from some plants. The combination of such 
MDR inhibitors with antibiotics in vitro has shown that the activities of some antibiotics can be 
dramatically increased even against antibiotic resistant strains of bacteria. The large varieties of 
compounds produced by plants have proved to have therapeutic potentials as antimicrobials and as 
resistance modifiers. The African biosphere which is endowed with the highest plant species 
biodiversity promises to be a potential source of therapeutically useful compounds, especially from 
the perspective of their potentials in combination with antimicrobial chemotherapy which should form 
the subject of further extensive study. 
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CHAPTER 3 
In vitro antibacterial regimes of crude aqueous and acetone extracts of Garcinia kola seeds 
 
ABSTRACT 
Aqueous and acetone extracts of Garcinia kola seeds were screened for activity against 27 bacterial 
isolates at 30 mgml-1 and 10 mgml-1 respectively. The aqueous extracts showed activity mainly 
against Gram positive organisms with MIC values ranging from 5 – 20 mgml-1. The acetone extract 
showed activity against both Gram negative and Gram positive organisms with MIC values ranging 
from 0.156 - 10 mgml-1. The bactericidal activity of the acetone extract was evaluated against 
Staphylococcus aureus ATCC 6538 and Proteus vulgaris CSIR 0030 by time-kill assay. The extract 
showed rapid bactericidal activity achieving a 3.097 Log10 reduction in counts within 4 hours at 
0.3125 mgml-1 against S. aureus ATCC 6538 and complete eradication of the organism in 8 hours at 
2 × and 3 × MIC levels. A 1.582 Log10 reduction in counts was observed against P. vulgaris CSIR 
0030 at 5 mgml-1 after 1 hour of exposure and a complete eradication was observed in 2 hours. We 
propose that acetone extract of Garcinia kola seeds possess strong bactericidal activities and can be 
chemotherapeutically useful in the treatment of bacterial infections in humans.   
Key words: Garcinia kola, acetone extract, bactericidal potency, killing rate, log reduction. 
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INTRODUCTION 
The problem of bacterial resistance to commonly used antibiotics has necessitated the search for 
newer and alternative compounds for the treatment of drug resistant infections and the high cost of 
conventional drugs particularly in resource poor communities of the developing world has led to the 
increased use of plants as an alternative for the treatment of infectious diseases. Medicinal plants 
have for generations been used for the treatment of ailments including infectious diseases. Several 
findings on the chemotherapeutic potentials of some plants have shown that they can be sources of 
antimicrobial compounds of value (Rios and Recio, 2005).  
Garcinia kola (Heckel), of the family of Guttiferae is a tropical tree of evergreen forests found in moist 
semi deciduous forest zones and savannah (Agyili et al., 2006). It is cultivated and distributed 
throughout West and Central Africa where it is valued for its medicinal properties. The medicinal 
properties of the plant have been a subject of numerous investigations. The seeds commonly known 
as bitter kola are used by communities for the treatment of bronchitis and throat infections (Iwu et al., 
1999). It is also used to prevent and relieve colic, cure head or chest colds and relieve cough 
(Farombi, 2000). The stems and twigs of the plant are used as chewing sticks in maintenance of oral 
hygiene (Ndukwe et al., 2005). 
Aqueous, ethanolic and petroleum ether extracts of the seeds have been observed to possess 
antibacterial properties (Ezeifeka et al., 2004), and Kolaviron, (a fraction of the defatted ethanol 
extract of the seed, containing Garcinia biflavonoid GB1, GB2 and kolaflavonone) has been reported 
to possess numerous therapeutic potentials (Farombi et al., 2002; Uko et al., 2001) along with such 
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components as mixtures of phenolic compounds, biflavonoids, xanthones, benzophenones and 
related triterpenes (Han et al., 2005).   
While numerous work have been done on the antimicrobial potentials of this plant, the overwhelming 
majority of the studies have concentrated on oral and respiratory tract pathogens (Akoachere et al., 
2002; Ndukwe et al., 2005), thus underestimating the antimicrobial potentials of the plant. Also, 
reports so far available on the antibacterial potentials of the seed show that activity has been 
demonstrated for the aqueous, ethanolic and petroleum ether extracts of the seed (Ezeifeka et al., 
2004). There are no documented reports in literature on the antimicrobial potentials of the acetone 
extract of the seeds, despite the fact that acetone has been shown to be an efficient extractant of 
bioactive components (Eloff, 1998). In addition, while previous researchers have used MICs and 
MBCs as prediction tools for antimicrobial action of the plant extracts, there are  limitations to the use 
of such data since it does not consider time-related antimicrobial effects (Kiem and Schentag, 2006), 
such as killing rate.  The bactericidal potencies of the extracts of the plant in terms of the kinetics of 
bacterial death of the extracts of the seeds have not been reported. In this paper, we report the 
antibacterial potentials of the aqueous and acetone extracts of the seeds of Garcinia kola against a 
widened panel of bacterial pathogens especially those not normally related to respiratory tract 
infections, and using the killing rate of the extract as predicting tool of their bactericidal efficiency. 
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MATERIALS AND METHODS 
Plant material 
This study was conducted at the University of Fort Hare’s Department of Biochemistry and 
Microbiology between the period April to July 2007. The plant material was prepared following the 
description of Farombi (2000). Peeled seeds of Garcinia kola were cut into pieces and dried in an 
oven at 40 oC for 48 hours. The material was then ground into a powder using a mechanical blender.  
Preparation of extracts 
The acetone and aqueous extracts of the plant were prepared in accordance to the description of 
Basri and Fan (2005). One hundred grams of seed powder was extracted in two steps with 500 ml 
and 300 ml of the respective solvent for 48 hour. Aqueous extracts were freeze dried at -50 oC under 
vacuum and acetone extracts were concentrated under reduced pressure using a rotary evaporator 
at 50 oC. The concentrated acetone extracts were then allowed to dry at room temperature to a 
constant weight. When not immediately used, the extracts were stored in air tight bottles at 4 oC.  
Bacterial isolates used in the study 
Bacterial strains used in this study consisted of reference strains obtained from the South African 
Bureau of Standards (SABS), namely, Escherichia coli ATCC 8739, Escherichia coli ATCC 25922, 
Staphylococcus aureus ATCC 6538, Streptococcus faecalis ATCC 29212, Bacillus cereus ATCC 
10702,  Bacillus pumilus ATCC 14884, Pseudomonas aeruginosa ATCC 7700, Enterobacter cloacae 
ATCC 13047, Klebsiella pneumoniae ATCC 10031, Klebsiella pneumoniae ATCC 4352, Proteus 
vulgaris ATCC 6830, Proteus vulgaris CSIR 0030, Serratia marcescens ATCC 9986, Acinetobacter 
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calcoaceticus Aci1, Acinetobacter calcoaceticus Aci2. Also included in this study were environmental 
bacterial strains of Klebsiella pneumoniae, Bacillus subtilis, Shigella flexineri, Salmonella spp, 
Staphylococcus epidermidis, Pseudomonas aeruginosa, Proteus vulgaris, Enterococcus faecalis, E. 
coli, Staphylococcus aureus, Micrococcus luteus and Micrococcus kristinae.  
Assay for antibacterial activity  
The antibacterial activities of the crude extracts were carried out using the agar dilution method 
(Afolayan and Meyer, 1997). Stock solutions of the extract were prepared by reconstituting the dried 
extract in the extracting solvents. This was used to prepare dilutions of the extract in molten Mueller 
Hinton agar maintained in a water bath at 50 oC to achieve concentrations of 30 mgml-1 for the 
aqueous extract and 10 mgml-1 for the acetone extract, while also achieving a final acetone 
concentration of 5% in the acetone extract media. An inoculum of each test organism prepared as 
described by Nostro et al. (2000) was used to seed the agar plates by streaking in duplicates. The 
inoculated plates were incubated under aerobic conditions at 37 oC for 24 hours.  Positive controls 
consisted of extract free plates of Mueller Hinton agar inoculated with the test organism and negative 
control consisting of uninoculated plates. Control plates for the acetone extract consisted of Mueller 
Hinton agar plates with 5% acetone (which represented the final acetone concentration in the test 
plates). The absence of growth on the test plate compared with the positive control was used to 
indicate the inhibitory activity of the extracts (Afolayan and Meyer, 1997).  
Determination of the Minimum Inhibitory Concentration (MIC)  
The minimum inhibitory concentration of the extracts was determined using the agar dilution method 
following the standard protocol of the European Committee for Antimicrobial Susceptibility Testing 
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(EUCAST, 2000). Acetone extracts were diluted in such a way that the highest concentration of the 
solvent in agar was 5% (at this concentration, the solvent was found to have no inhibitory effect on 
the test organisms). Control plates contained extract free Mueller Hinton agar plates for the aqueous 
extracts. Control plates for the acetone extract contained 5% acetone. Plates were inoculated with 
overnight broth cultures of the test organisms diluted 1:100 with fresh sterile nutrient broth and 
incubated for 18 hours at 37 oC. The MIC was defined as the lowest concentration of the extract that 
was able to inhibit the visible growth of the test organism (EUCAST, 2000).   
Determination of the rate of kill of the crude extracts 
The rate of kill determination was done by monitoring of bacterial cell death over time as in 
accordance with the description of Okoli and Iroegbu, (2005). The assay was done for the acetone 
extract on Staphylococcus aureus ATCC 6538 and Proteus vulgaris CSIR 0030 as representative 
Gram positive and Gram negative organisms respectively. The inoculum was prepared using the 
colony suspension method following the guidelines described in the EUCAST Discussion Document, 
(2003). The resultant suspension was diluted 1:100 with fresh sterile broth and used to inoculate 50 
ml volumes of Mueller Hinton broth incorporated with extract at multiples of the MIC to a final cell 
density of approximately 5×105 cfuml-1. The flasks were incubated with shaking at 37 oC. Samples 
(100 µl) were withdrawn at intervals and diluted appropriately and known volumes of diluted samples 
were plated out in triplicates on Mueller Hinton agar. Plates were incubated at 37 oC for 24 hours 
after which the numbers of survivors were enumerated. Controls consisted of extract free Mueller 
Hinton broth inoculated with the test organism. 
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RESULTS 
Of the twenty seven bacterial isolates tested 17 were susceptible to the aqueous extract at a 
concentration of 30 mgml-1, while 24 isolates were susceptible to the acetone extract at a 
concentration of 10 mgml-1 (Table 1). Enterobacter cloacae ATCC13047, Klebsiella pneumoniae 
ATCC10031 and an environmental strain of Klebsiella pneumoniae were not susceptible to either the 
aqueous or acetone extract of the seeds. The minimum inhibitory concentrations (MIC) of the 
aqueous extract ranged between 5 and 20 mgml-1, while that of the acetone extracts were generally 
lower and ranged between 0.156 and 10 mgml-1 (Table 2). Differences were also observed in the 
susceptibilities of Gram positives (MIC values, 0.156 - 0.625 mgml-1) and Gram negative test 
organisms (2.5 - 10 mgml-1) to the acetone extract.  
The killing rate studies revealed that the acetone extract exhibited bactericidal activities against 
Staphylococcus aureus ATCC 6538 and Proteus vulgaris CSIR 0030 resulting in the eradication of 
approximately 105 cfuml-1 in 2 to 8 hours. Both the 2 × MIC and 3 × MIC of the acetone extract killed 
100% of Staphylococcus aureus ATCC 6538 in 8 hours (Figure 1), while total eradication of Proteus 
vulgaris CSIR 0030 was achieved in 2 hours by the 2 × MIC of the extract against the organism 
(Figure 2).  
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Table 1: Antimicrobial activity of Aqueous and Acetone extracts of Garcinia kola seeds against bacterial 
isolates 
Crude Extracts 
 
          Test organism                                    
 
 
Aqueous  
30 mgml-1 
Acetone  
10 mgml-1 
Escherichia coli ATCC 8739 - + 
Escherichia coli ATCC 25922 - + 
Staphylococcus aureus ATCC 6538 + + 
Streptococcus faecalis ATCC 29212 + + 
Bacillus cereus ATCC 10702 + + 
Bacillus  pumilus ATCC 14884 + + 
Pseudomonas aeruginosa ATCC 7700 + + 
Enterobacter cloacae ATCC 13047 - - 
Klebsiella pneumoniae ATCC 10031 - - 
Klebsiella pneumoniae ATCC 4352 - + 
Proteus vulgaris ATCC 6830 + + 
Proteus vulgaris CSIR 0030 + + 
Serratia marcescens ATCC 9986 - + 
Acinetobacter calcoaceticus Aci1 + + 
Acinetobacter calcoaceticus Aci2 + + 
Klebsiella pneumoniae  - - 
Bacillus subtilis  + + 
Shigella flexineri  - + 
Salmonella spp  - + 
Staphylococcus epidermidis  + + 
Pseudomonas aeruginosa  + + 
Proteus vulgaris  + + 
Enterococcus faecalis  + + 
Escherichia coli  - + 
Staphylococcus aureus  + + 
Micrococcus luteus + + 
Micrococcus kristinae + + 
Key: + susceptible to the extract, - not susceptible 
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Table 2: The minimum inhibitory concentrations (MIC) of the crude extracts of Garcinia kola. 
MIC Values of Crude extracts (mgml-1) Test organism 
Aqueous Acetone 
Staph.  aureus ATCC 6538 10 0.156 
Str. faecalis ATCC 29212 10 0.3125 
B. cereus ATCC 10702 10 0.156 
B. pumilus ATCC 14884 5 0.156 
Ps. aeruginosa ATCC 7700 10 10 
P. vulgaris ATCC 6830 20 5 
P. vulgaris CSIR 0030 20 2.5 
B.  subtilis 10 0.156 
Staph. epidermidis 10 0.3125 
P. vulgaris 20 5 
Ent. faecalis 20 0.3125 
Staph. aureus 10 0.3125 
Micro. luteus 10 0.625 
Micro. kristinae 10 0.625 
E. coli ATCC 8739 ND 10 
E. coli ATCC 25922 ND 10 
Aci. calcoaceticus Aci1 ND 5 
Aci. calcoaceticus Aci2 ND 5 
 
Key: ND - not done. 
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Figure 1: The killing rate regimes of acetone extract of Garcinia kola on Staphylococcus aureus 
ATCC 6538. 
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Figure 2: The killing rate regimes of acetone extract of Garcinia kola on Proteus vulgaris CSIR 0030 
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DISCUSSION 
Garcinia kola is a plant that has shown tremendous potential as a source of novel chemotherapeutic 
agents. The plant is extensively utilized in traditional medicinal practices in West and Central Africa. 
It is therefore one of the prime medicinal plants of Africa that can provide relief to the millions of the 
poor people of the continent if its potentials are adequately explored.  
The antibacterial activity of the aqueous extract of the seed from this study was observed mainly 
against Gram positive organisms with limited activity against Gram negatives. Results from this study 
confirm that the aqueous extracts of the seeds of Garcinia kola seeds possess antibacterial 
properties thus validating the traditional use of the seeds in treatment of oral and respiratory tract 
infections. The limited activity against Gram negative bacterial isolates is in agreement with the 
findings of Ezeifeka et al. (2004), who reported that crude aqueous extracts of Garcinia kola seeds 
had activity against S. aureus and Ps. aeruginosa but lacked activity against E. coli by disc diffusion, 
although it is worth noting that the concentration of the extract used in that study was not reported. It 
is likely that the aqueous extracts can exhibit inhibitory activity against Gram negative organisms at 
higher concentrations than was used in this study. We considered 30 mgml-1 comparable to the 
levels often reported in literature for the screening of crude extracts in the absence of a standard. 
Ndukwe et al. (2005) observed that aqueous extracts of Garcinia kola stems and twigs had no 
antimicrobial activity against reference strains of E. coli and Pseudomonas aeruginosa but had 
activity against Staphylococcus aureus and Bacillus cereus, although the same extracts exhibited 
activity against clinical isolates of Gram negative organisms from cases of oral infections. The 
differences in the susceptibilities of Gram positive and Gram negative bacteria to plant extracts have 
been observed by several researchers (Nostro et al., 2000; Suffredini et al., 2006; Parekh and 
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Chanda, 2006). Gram negative bacteria are inherently resistant to antimicrobials and this has been 
ascribed to the combined exclusion of the antimicrobial compounds by the double membrane barrier 
(present in this group) and transmembrane efflux (Zgurskaya and Nikaido, 2000).  
In contrast with the aqueous extract, the acetone extract showed activity against both Gram positive 
and Gram negative organisms at 10 mgml-1 (Table 1). Results from this study confirm that acetone is 
a potentially good solvent for the extraction of bioactive compounds of Garcinia kola. Acetone has 
been observed to be a relatively more efficient extractant of bioactive compounds. Eloff (1998), in a 
comparison of ethanol, acetone, methanol, methylenedichloride, methanol/chloroform/water and 
water) observed acetone to be the best in terms of the quantity and diversity of compounds extracted 
and water, the least.  It is anticipated that the acetone extract of Garcinia kola seeds contains a 
higher quantity and concentration of active compounds than the aqueous extract since water is only 
able to extract hydrophilic compounds. 
The MIC values for the aqueous extracts which ranged from 5 to 20 mgml-1 were higher than the 
values for the acetone extract which ranged from 0.156 to 10 mgml-1. Gram positive bacteria showed 
more susceptibility to the acetone extract than Gram negatives. It is likely that the extraction with 
acetone could be resulting in an increased diversity of compounds that interact with each other in a 
synergistic way resulting in an increased activity of the active principles (Tegos et al., 2002). The 
interaction might include the increased permeation of the cell membrane of Gram negative bacteria 
which often presents an intrinsic resistance barrier. 
Because the acetone extract showed more activity than the aqueous extract, its bactericidal efficacy 
was investigated against Staphylococcus aureus ATCC 6538 and Proteus vulgaris CSIR 0030 by 
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assay of bacterial death time.  The extract showed good bactericidal activity at 0.3125 mgml-1 (2 × 
MIC) and 0.468 mgml-1 (3 × MIC) against Staphylococcus aureus (Figure 1). Reductions of 3.097 
and 3.370 Log10 cfuml-1 were achieved at 0.3125 and 0.468 mgml-1 respectively against 
Staphylococcus aureus ATCC 6538 after 4 hours of exposure. At 8 hours, no survivors could be 
recovered in both the 2× and 3× MIC reaction cultures. The rate of killing of Staphylococcus aureus 
ATCC 6538 by the extract appeared to be both concentration and time dependent. Preliminary 
investigations revealed that the extract was rapidly bactericidal at 0.625 mgml-1 (4 × MIC) achieving a 
complete elimination of the organism after 30 minutes of exposure (data not shown), while at 1 × 
MIC, it seemed to have a Bacteriostatic effect on the test organism with no major changes on the 
bacterial load with time (data not shown). The extract exhibited a strong bactericidal efficacy against 
Proteus vulgaris CSIR 0030 at 5 mgml-1 (Figure 2). A 1.258 Log10 reduction in counts of the test 
organisms was achieved after 1 hour of exposure with a complete eradication after 2 hours.  
A 3 Log10 or ≥ 99.9% reduction in viable bacterial density in an 18 - 24 hours period is the generally 
accepted definition of bactericidal activity in antibiotics (Pankey and Sabath, 2004). Although the MIC 
values of the crude extract were higher than often observed for antibiotics (Anadiotis et al., 2002; 
Osburne et al., 2006), the bactericidal potencies against the two test organisms showed a similar 
pattern to that often exhibited by antibiotics.  
The bactericidal potentials of the extracts of G. kola from this study represent a significant finding on 
the therapeutic potentials of this plant. Since the acetone extracts showed such strong bactericidal 
activity against the test organisms used in this study, it is expected that if the compounds responsible 
for this activity could be isolated and crystalised, therapeutically useful drugs could be obtained. 
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 CONCLUSION  
This study has shown that the aqueous and acetone extracts of the seeds of Garcinia kola possess 
antibacterial activity with the acetone extract exhibiting activity against both Gram negative and Gram 
positive organisms. This confirms that acetone can be a good solvent for the extraction of biologically 
active components of the plant and also suggests that the acetone fraction could compare favorably 
well with standard antibiotics with regards to time of action, and this is the subject of an 
accompanying paper. 
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CHAPTER 4 
In vitro antibacterial activities of crude extracts of Garcinia kola seeds against wound sepsis 
associated Staphylococcus strains 
ABSTRACT 
Extracts of Garcinia kola seeds were evaluated for their activity against four Staphylococcus strains 
isolated from wound sepsis specimens. Three of the isolates were identified by 16S rDNA 
sequencing as Staphylococcus aureus with the GenBank Accession numbers, EU244633, 
EU244634, EU244636, and another was identified as Staphylococcus sciuri (Accession number 
EU244635). The aqueous, methanol and acetone extracts of Garcinia kola seeds showed activity 
against all four isolates at 30 mgml-1 (aqueous extract) and 10 mgml-1 (acetone and methanol 
extracts). The MIC values for the aqueous extract were the same (10 mgml-1) for all the isolates. The 
acetone and methanol extracts had lower MIC values in the ranges of 0.3125 - 0.625 mgml-1. The 
acetone extract showed strong bactericidal activity against Staphylococcus aureus strain OKOH3 
resulting in a 2.70 Log10 reduction in counts at 1.25 mgml-1 (2 × MIC) within 4 hours of exposure and 
a complete elimination of the organism after 8 hours. The same extract was weakly bactericidal 
against Staphylococcus aureus strain OKOH1, achieving only a 2.92 Log10 reduction in counts at 
1.25 mgml-1 (4 × MIC) in 24 hours. The interactions between the acetone extract and antibiotics were 
largely additive and indifferent with no combinations showing classical synergistic interactions. We 
conclude that extracts of Garcinia kola seeds can potentially be useful in the treatment of 
staphylococcal wound infections.  
Key words: Staphylococcus; wound sepsis; Garcinia kola; antistaphylococcal activity; antibiotic 
potentiation. 
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INTRODUCTION 
The genus Staphylococcus is widely distributed in nature being part of the indigenous microflora of 
the skin and nasal cavities of healthy persons. This association with the skin presents the organisms 
with an opportunity to cause local infection of wounds. Among members of this genus, 
Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus saprophyticus and 
Staphylococcus haemolyticus are some of the species causing community and nosocomial human 
infections (Oliveira et al., 2006). In particular, Staphylococcus aureus is the causative agent of a wide 
range of diseases, ranging from carbuncles and food poisoning, through more serious wound-related 
infections, to life threatening conditions, such as bacteremia, necrotizing pneumonia, and 
endocarditis (Holden et al., 2004). This species is capable of expressing a variety of virulence factors 
that it is almost always considered medically relevant when encountered in clinical specimens. 
In addition to strains of Staphylococcus being significant pathogens in terms of the variety of 
infections that they cause, the organisms have been recognized as having the ability to develop 
changes in their sensitivity to antimicrobials (Oliveira et al., 2006). In the case of Staphylococcus 
aureus, strains resistant to methicillin (MRSA) were first identified following the introduction of the 
antibiotic in clinical use in the 1960s (Lowy, 2003). At present MRSA strains are a common 
occurrence and are now virtually resistant to all beta-lactam antibiotics (Cook, 1998; Archer, 1998). 
In addition to the problem of treatment failure in MRSA infections, the infections have often been 
associated with severe illnesses resulting in increased hospitalization periods and mortality (Rello et 
al., 1994; Engemann et al., 2003). Until recently, the glycopeptide antibiotic vancomycin has been 
used as the drug of last resort for many MRSA infections, but recent trends show that vancomycin 
resistant strains have also emerged (Tenover et al., 2004). Reports of isolated cases of resistance to 
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the newest anti-staphylococcal agent linezolid (a member of the oxazolidinone group that has been 
heralded as a solution to MRSA infections) have also been noted (Wilson et al., 2003). 
Owing to their popular use in traditional medicine for the treatment of various ailments including 
infectious diseases, interest in medicinal plants as a source of novel antimicrobial compounds has 
been growing. A number of studies have validated the use of plants in the treatment of disease 
conditions (Samie et al., 2005; Akinpelu and Onakoya, 2006). A typical example is Garcinia kola, a 
tropical plant of the African Continent which has been a subject of investigation as a potential source 
of antimicrobial compounds (Madubunyi, 1995; Han et al., 2005).  
While it is common practice that standard reference cultures of test isolates are used in evaluating 
the antimicrobial activity of plant extracts, the use of clinical isolates of pathogenic organisms may 
provide a more relevant and accurate prediction of the therapeutic potentials of plant extracts (Rios 
and Recio, 2005). While the antibacterial activity of Garcinia kola seed extracts has been 
demonstrated against reference strains of Staphylococcus (Ezeifeka et al., 2003; Akoachere et al 
2003), their efficacy against clinical strains of this organism particularly those associated with wound 
sepsis has not been documented. In this paper, we report the antibacterial activity of extracts of 
Garcinia kola seeds against clinical isolates of Staphylococcus obtained from cases of wound sepsis 
as well as the potentials of the plant extracts in combination with six selected antibiotics.  
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MATERIALS AND METHODS 
Isolation and identification of Staphylococci from wound sepsis specimens 
Pus swabs obtained from three patients presenting with septic abrasion of the hip, wrist and elbow 
respectively were suspended in sterile physiological saline. One milliliter of the suspension was 
inoculated into 50 ml of sterile nutrient broth and incubated aerobically at 37 oC for 24 hours. At the 
end of the incubation period, the broth cultures were streaked for isolation on mannitol salt agar. 
Presumptive Staphylococcus colonies were identified as golden yellow, circular, convex colonies that 
ferment mannitol. One colony from each specimen displaying the above morphology was purified by 
subculturing onto nutrient agar. Where more than one type of colonies displaying the cultural 
characteristics of Staphylococcus were observed on each plate, one colony from each colony type 
was selected and purified by subculturing onto nutrient agar. The presumptive Staphylococcus 
isolates were processed for molecular identification by 16S rRNA gene amplification and sequencing. 
Amplification, sequencing and analysis of the 16S rRNA gene of the bacterial isolates 
Total genomic DNA was isolated from LB-grown bacterial cultures using the QIAamp DNA miniprep 
kit, following the manufacturer’s instructions and used directly as template for PCR amplification. The 
16S rRNA genes of the bacterial isolates were amplified with the oligonucleotide primers: 63f (5'–
CAGGCCTAACACATGCAAGTC-3') and 1387r (5'–GGGCGG(A/T)GTGTACAAGGC-3') described 
by Marchesi et al. (1998).  The amplification reaction mixture contained standard Taq amplification 
buffer, 100 µM (each) deoxyribonucleotide triphosphate, 0.5 µM (each) primers, genomic DNA and 
2.5 U of Taq DNA polymerase in a 50 µl reaction volume. The cycling parameters were 94 oC for 2 
min followed by 30 cycles of 92 oC for 30 s, 55 oC for 30 s, and 75 oC for 45 s, with a final elongation 
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step of 75 oC for 5 min. Amplification products were directly cycle sequenced using the Spectrumedix 
SCE2410 genetic analysis system with 24 capillaries. Big Dye version 3.1 dye terminator cycle 
sequencing kit (Applied Biosystems) was used for the sequencing reactions. The analysis of the 16S 
rRNA gene sequences of the bacterial isolates were carried out by comparing them with those in the 
GenBank database (http://www.ncbi.nlm.nih.gov) by using BLAST (Altschul et al., 1997) to determine 
the most similar sequences. 
Preparation of plant extracts 
The extracts of the plant were prepared in accordance with the description of Basri and Fan (2005). 
One hundred grams of seed powder was steeped in 500 ml of the respective solvent (water, acetone 
and methanol) for 24 hours with shaking. The resultant extract was centrifuged at 3000 rpm for 5 
minutes at 4 oC. The supernatant was then filtered through a Whatman No.1 filter paper while the 
residue was used for a second extraction with 300 ml of the respective solvents. After the second 
extraction process, the aqueous extract was freeze-dried at -50 oC under vacuum whereas the 
acetone and methanol extracts were concentrated under reduced pressure using a rotary evaporator 
at 50 and 65 oC respectively. The concentrated extracts were then allowed to dry at room 
temperature to a constant weight. 
Preparation of bacterial inocula 
The inocula of the test organisms were prepared using the colony suspension method (EUCAST, 
2003). Colonies picked from 24 hour old cultures grown on nutrient agar were used to make 
suspensions of the test organisms in saline solution (0.85% NaCl) to give an optical density of 
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approximately 0.1 at 600 nm. The suspension was then diluted 1:100 by transfer of 0.1 ml of the 
bacterial suspension to 9.9 ml of sterile nutrient broth before use. 
Antibiotics used in this study 
The following antibiotics which were available as powders were used in this study: Penicillin G 
sodium (Duchefa); Amoxycillin (Duchefa); Chloramphenicol (Duchefa); Tetracycline hydrochloride 
(Duchefa); Erythromycin (Duchefa) and Ciprofloxacin (Fluka).  
Assay for antistaphylococcal activity  
The antistaphylococcal activities of the crude extracts were carried out using the agar dilution 
method (Afolayan and Meyer, 1997). The extracts were incorporated directly into molten nutrient 
agar at 50 oC to achieve concentrations of 30 mgml-1 for the aqueous extract and 10 mgml-1 for the 
acetone and methanol extracts. Dilutions of the acetone and methanol extracts were done in such a 
way that the final solvent concentration was 5% in the media. Standardised bacterial suspensions 
were used to inoculate the agar plates by streaking in duplicates. The inoculated plates were 
incubated under aerobic conditions at 37 oC for 24 hours. Positive controls consisted of extract free 
plates of nutrient agar inoculated with the test organisms. For the acetone and methanol extracts, 
controls consisted of nutrient agar plates with 5% of the respective solvent (which represented the 
final solvent concentration in the test plates). The absence of growth on the test plates compared 
with the positive controls was used to indicate the inhibitory activity of the extracts (Afolayan and 
Meyer, 1997).  
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Determination of the Minimum Inhibitory Concentrations (MIC) 
The minimum inhibitory concentrations of the extracts and antibiotics were determined using the agar 
dilution method following the standard protocol of the European Committee for Antimicrobial 
Susceptibility Testing (EUCAST, 2000a). The extracts and antibiotics were incorporated into molten 
nutrient agar at 50 oC and allowed to solidify at room temperature. The dilutions of the extract ranged 
from 0.039 – 10 mgml-1 (acetone and methanol) and 0.625 - 20 mgml-1 (aqueous). The antibiotic test 
plates had concentrations ranging from 0.004 – 512 mgl-1.  Standardised inocula of test strains were 
used to seed the test plates in duplicates by streaking. Plates were incubated at 37 oC for 24 hours. 
The controls consisted of extract- free and antibiotic- free nutrient agar plates. The MIC value was 
taken as the lowest concentration of the extract or antibiotic showing complete lack of growth after 
the incubation period (EUCAST, 2000a).  
Rate of kill experiment of the crude acetone extract 
The rate of kill determination for the acetone extract was done by assaying of bacterial cell death 
over time following the description of Okoli and Iroegbu (2005). The assay was carried out using two 
of the Staphylococcus aureus strains, OKOH1 and OKOH3. The assay method was a broth 
macrodilution based technique, with the extract incorporated into 50ml nutrient broth in flasks, at 
concentrations of 1, 2 and 4 times the MIC values. Control flasks consisted of extract-free nutrient 
broth. The flasks were inoculated with standardised bacterial suspensions to a final cell density of 
approximately 105 cfuml-1. The inoculated flasks were immediately incubated at 37 oC with shaking. 
At intervals of 1, 2, 4, 8, 12 and 24hours, samples (100 µl) were withdrawn from each flask, diluted in 
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tenfold series and plated out in duplicates on nutrient agar. Plates were incubated at 37oC for 
24hours after which the number of survivors were enumerated.   
Extract - Antibiotic Combination Studies 
The effect of combinations of the acetone extract of Garcinia kola seeds and antibiotics was 
evaluated by the use of the rate of kill assay following the descriptions of White et al. (1996) and 
Pankey et al. (2005) with modifications. The extract and antibiotics were incorporated into 50 ml of 
nutrient broth in flasks at concentrations equivalent to their respective MIC values for each test 
strain. Positive controls, consisting of the extract and antibiotic alone at the test concentrations were 
included in each experiment. The negative controls consisted of antibiotic- and extract-free broth. 
The test and control flasks were inoculated with standardised suspensions of the test organisms to a 
final inoculum density of approximately 105 cfuml-1. Immediately after inoculation, aliquots (100 µl) of 
the negative control flasks were taken, serially diluted in sterile saline and plated on nutrient agar in 
order to determine the zero hour counts. The test flasks were then incubated at 37 oC with shaking at 
120 rpm. After 24 hours of incubation, aliquots (100 µl) were withdrawn from each test and control 
flask, serially diluted in sterile saline and plated (100 µl) on nutrient agar in duplicates. To improve 
the visual observation of colonies in the agar, 1 ml of a 0.5% aqueous solution of 2,3,5 triphenol 
tetrazolium chloride (Neugebauer and Gilliland, 2005) was added to 100 ml of molten agar at 50 oC 
before plating. The plates were then incubated at 37 oC for 24 hours under aerobic conditions after 
which, the number of colonies were enumerated.  
The interactions between the extract and antibiotics were considered synergistic if there was a 
decrease of ≥ 2 Log10 cfuml-1 in colony counts at 24 hours by the combination compared to the most 
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active single agent (Pankey et al., 2005). Additivity or indifference was defined as a < 2 Log10 cfuml-1 
change in the average of viable counts at 24 hours for the combination, in comparison with the most 
active single drug. Antagonism was defined as a ≥ 2 Log10 cfuml-1 increase in colony counts at 24 
hours by the combination compared with that by the most active single agent (Pankey et al., 2005; 
Lee et al., 2006). 
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RESULTS 
The polymerase chain reaction amplification of the 16S rRNA gene of the bacterial isolates resulted 
in the expected 1.3 kb amplicons (Figure 1). Partial sequencing of the amplified DNA revealed that 
three of the isolates had high (≥ 98%) sequence homology to Staphylococcus aureus and have since 
been deposited in GenBank with Accession numbers EU244633, EU244634 and EU244636, while 
one of the isolates had a 100% sequence homology to Staphylococcus sciuri and has also been 
deposited in GenBank with Accession number EU244635 (Table 1). 
 
1       2      3       4      5       6 
 
 
Figure 1:  Gel picture of the 16S rRNA gene amplification for OKOH1 (Lane 2), OKOH2A (Lane 3), 
OKOH2B (Lane 4) and OKOH3 (Lane 5). Lane 1 represents the negative control and Lane 6 is a 
molecular weight ladder. 
1.3 kb 
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Table 1: Identity of bacterial isolates based on 16 rDNA sequencing. 
Specimen Source Isolate Identity GenBank Accession  Number 
 
 
 
Septic abrasion (Hip) Staphylococcus aureus OKOH1 EU244633 
Septic abrasion (Wrist) Staphylococcus aureus OKOH2A EU244634 
Septic abrasion (Wrist) Staphylococcus sciuri  OKOH2B EU244635 
Septic abrasion (Elbow) Staphylococcus aureus OKOH3 EU244636 
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The susceptibility profiles of the Staphylococcus isolates to the extracts of Garcinia kola seeds 
revealed that all the strains showed susceptibility to the aqueous extract at 30 mgml-1 as well as to 
the methanol and acetone extracts at 10 mgml-1 (Table 2). All the isolates had identical MIC values 
for the aqueous extract (10 mgml-1) and the methanol extract (0.3125 mgml-1) (Table 3). 
Susceptibility to the acetone extract was slightly higher for the Staphylococcus aureus strains, 
OKOH1 and OKOH2A with MIC values of 0.3125 mgml-1, while Staphylococcus aureus OKOH3 and 
Staphylococcus sciuri OKOH2B, had MIC values of 0.625 mg ml-1 (Table 3). 
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Table 2: Susceptibility of the staphylococcal isolates to extracts of Garcinia kola seeds. 
 Test Isolates Crude Extracts 
  
Aqueous 
30 mgml-1 
Methanol 
10 mgml-1 
Acetone 
10 mgml-1 
Staphylococcus aureus OKOH1 + + + 
Staphylococcus aureus OKOH2A + + + 
Staphylococcus sciuri OKOH2B + + + 
Staphylococcus aureus OKOH3  + + + 
   
  Key: + denotes susceptibility 
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 Table 3. Minimum inhibitory concentration (MIC) values for the crude extracts of Garcinia kola seeds and 
antibiotics against the Staphylococcus isolates. 
Test Isolate 
 
Extract 
MIC values (mgml-1) 
 
 
Antibiotics 
MIC values (mgl-1) 
 
 
  Aq Met Ace Amx PenG Chlo Tet Ery Cip 
S. aureus OKOH1 10 0.312 0.312 1 0.25 4 0.25 0.25 0.5 
S. aureus OKOH2A 10 0.312 0.312 1 0.5 4 0.25 0.5 0.5 
S.  sciuri OKOH2B 10 0.312 0.625 0.25 0.06 4 0.25 0.5 1 
S. aureus OKOH3  10 0.312 0.625 1 1 4 0.25 0.5 0.5 
 
Key: Aq - Aqueous; Met - Methanol; Ace - Acetone; Amx- Amoxycillin; PenG- Penicillin G; Tet-Tetracycline; 
Chlo- Chloramphenicol; Ery- Erythromycin; Cip- Ciprofloxacin 
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Two of the isolates, Staphylococcus aureus OKOH1 and OKOH3 were used to investigate the 
bactericidal activity of the acetone extract by time-kill assays. The extract was strongly bactericidal 
against isolate OKOH3 resulting in a 2.70 Log10 reduction in counts at 1.25 mgml-1 (2× MIC) within 4 
hours of exposure (Figure 2).  A complete elimination of the test organism was achieved after 8 
hours of exposure. In contrast, the extract was weakly bactericidal against isolate OKOH1 achieving 
only a 2.92 Log10 reduction in counts at 1.25 mgml-1 (4× MIC) in 24 hours (Figure 3). At the MIC 
(0.3125 mgml-1), the extract exhibited limited bactericidal activity during the first 8 hours but the 
organism showed evidence of regrowth as the exposure time was extended to 24 hours (Figure 3). 
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Figure 2. Effect of exposure to the acetone extract of Garcinia kola seeds on the viability of 
Staphylococcus aureus OKOH3. 
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Figure 3. Effect of exposure to the acetone extract of Garcinia kola seeds on the viability of 
Staphylococcus aureus OKOH1. 
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The effect of combinations of the acetone extract and antibiotics on the susceptibility of the 
Staphylococcus isolates is shown in Table 4. The efficacy of all the antibiotics against isolates 
OKOH1 and OKOH3 was marginally improved in the presence of the extract. The extract-antibiotic 
combinations achieved decreases in bacterial counts ranging from 0.62 to 1.66 Log10 cfuml-1 (Table 
4). In contrast, extract-antibiotic combinations involving isolates OKOH2A and OKOH2B produced 
slight increases in bacterial counts for all but two antibiotics, with increases ranging from 0.04 to 1.27 
Log10 cfuml-1 (Table 4). Only the combinations involving amoxycillin (on isolate OKOH2A) and 
tetracycline (on isolate OKOH2B) showed marginal potentiation of antibiotic activity. The interaction 
between penicillin G and the extract on isolate OKOH3, was the only one to produce a synergistic 
effect with a 3.90 Log10 (> 1000 times) potentiation (Table 4).  
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Table 4. The effect of combinations of acetone extract of G. kola seeds and antibiotics on Staphylococcus 
isolates. 
 
Changes in bacterial counts (Log10 cfuml-1 ) for the combination 
compared with the two agents used alone 
Test Organism Amx PenG Chlo Tet Ery Cip 
S. aureus OKOH1 -1.35(I) -1.38(I) -0.64(I) -1.66(I) -0.78(I) -0.62(I) 
S. aureus OKOH2A -0.19(I) 0.40(I) 0.44(I) 0.37(I) 0.51(I) 1.27(I) 
S. sciuri OKOH2B 0.13(I) 0.37(I) 0.26(I) -0.88(I) 0.13(I) 0.04(I) 
S. aureus OKOH3  -1.00(I) -3.90(S) -0.62(I) -0.73(I) -1.30(I) -0.82(I) 
 
Key: Amx - Amoxycillin; PenG - Penicillin G; Tet - Tetracycline; Chlo - Chloramphenicol; Ery - Erythromycin; 
Cip - Ciprofloxacin. (S) - Synergy; (I) - Indifference/Additivity 
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DISCUSSION 
Staphylococcus aureus is a prominent pathogen in hospital and community acquired infections as a 
major cause of wound suppuration (Archer, 1998). It is therefore always relevant when encountered 
in clinical specimens, particularly those of wound infections. The detection of Staphylococcus aureus 
in all the three specimens tested in this study underlines its importance as a cause of wound 
infections and is in agreement with the findings of other researchers such as Styers et al. (2006) and 
Moran et al. (2005) confirming that Staphylococcus aureus as a common pathogen frequently 
encountered in clinical specimens. In addition to Staphylococcus aureus, the coagulase negative 
Staphylococcus sciuri was also isolated from one of the specimens. Staphylococcus sciuri is a 
common inhabitant of the skin of rodents and other mammals such as dogs (Stepanovic et al., 2001). 
The organism may also be found as a colonizing bacterium in humans, with low carrier rates in the 
nasopharynx, skin and urogenital tract (Stepanovic et al., 2005). Occasionally, the organism has 
been isolated from patients with boils and wounds (Marsou et al., 1999). While Staphylococcus sciuri 
is not so frequently encountered in clinical specimens, its presence is significant as the organism has 
been reported to carry a number of resistance plasmids (Schwarz et al., 2002). Its co-infection with 
Staphylococcus aureus could therefore present problems of transmission of resistance genes to a 
true pathogen like Staphylococcus aureus.  
The observation that all the strains of Staphylococcus aureus were susceptible to the crude extracts 
of Garcinia kola at concentrations as low as 0.3125 mgml-1 supports the idea that extracts of this 
plant can be of value in the treatment of staphylococcal infections. The activity of the acetone and 
methanol extracts at concentrations of 0.3125 mgml-1, were comparable to that of other plant extracts 
reported to possess antistaphylococcal activity (Palombo and Semple, 2002; Voravuthikunchai and 
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Kitpipit, 2005). Garcinia kola seeds have been known to possess compounds such as biflavonoids, 
xanthones and benzophenones (Iwu et al., 1999). Some of these compounds such as Kolanone, 
hydroxybiflavononol (GB1) have been reported to have good antibacterial activity (Madubunyi, 1995: 
Han et al., 2005). The antistaphylococcal activity particularly against clinical isolates is a very 
important finding as it demonstrates the potential of this plant in the treatment of problematic 
infections.  
The killing rates experiments showed that the acetone extract possessed strong bactericidal activity 
against isolate OKOH3 achieving a > 99.9% (3 Log10) reduction in counts after 8 hours. The same 
extracts exhibited a relatively weaker activity against isolate OKOH1 achieving a 2.92 Log10 
reduction after 24 hours at 4× MIC. A greater than 99.9% killing activity in 24 hours is generally used 
as a standard of measurement of bactericidal efficacy (EUCAST, 2000b). The results also support 
the suggestion that extracts of this plant can be valuable in the treatment of some staphylococcal 
infections depending on the susceptibility of the infecting organism.  
According to the MIC breakpoint values recommended by the British Society for Antimicrobial 
Chemotherapy (BSAC) and (EUCAST) (2005), two of the Staphylococcus aureus isolates (OKOH2A 
and OKOH3) had MIC values (Table 3) higher than the breakpoints for penicillin G (breakpoint MICs; 
0.25 mgl-1). This could be a reflection of the general trend in beta-lactam resistance among strains of 
Staphylococcus aureus in hospital and community settings. On the other hand, Staphylococcus sciuri 
exhibited high sensitivity to the beta-lactam antibiotics (MIC values; 0.06 and 0.25 mgl-1 for penicillin 
G and amoxycillin respectively). Susceptibility to tetracycline and erythromycin was high with MIC 
values for all the isolates, lower than the breakpoints (2 mgl-1 tetracycline and 1 mgl-1 erythromycin), 
thus suggesting that therapy by these drugs could be effective. However the closeness of the 
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erythromycin MIC values to the breakpoint for isolates OKOH2A, OKOH2B and OKOH3 (MIC values; 
0.5 mgl-1) could be a sign of emerging low level resistance to this drug. Staphylococcus sciuri was 
the only isolate to be classified as resistant to ciprofloxacin. This could be confirming the quinolone 
resistance gene carrying capacity that organisms of this group are known of (Schwarz et al., 2002). 
The level of interaction between the acetone extract of Garcinia kola seeds and antibiotics was 
investigated by the time-kill assay. In this method, concentrations of the extract and antibiotics 
equivalent to the MIC values were used in combination. Results from this study revealed a lack of 
synergistic interactions (i.e. > 100 times potentiation) between the extract and antibiotics on most of 
the isolates (Table 4). However, results still showed a positive picture of the interactions with 
marginal improvements (additive interactions) in the bactericidal activity of some antibiotics 
particularly against isolates OKOH1 and OKOH3. The varying levels of enhancement of antibiotic 
activity by the extracts is consistent with previous findings involving combinations of plant extracts 
and antibiotics on Staphylococcus aureus strains such as Darwish et al. (2002) and Yang et al. 
(2005). The likely reason for the observed lack of synergy could be the concentrations of the extract 
and antibiotics used in this study. Den-Hollander et al. (1997) emphasized that when determining 
synergy between two drugs, one of the drugs should have a concentration which does not affect the 
bacterial growth of the test organism. We also observed that some studies on the combinational 
effects of plant extracts and antibiotics such as Al-hebshi et al. (2006) and Braga et al. (2005) 
employed sub-inhibitory concentrations of the extracts and antibiotics. In this study, both the extract 
and the antibiotics at the MIC had some level bactericidal activity on the test isolates (data not 
shown) and this is likely to have interfered with synergy detection.  
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The enhancement in the killing effect (additivity) of the antibiotics suggests that extracts of Garcinia 
kola seeds could be containing compounds that can improve the efficacy of antibiotics. Such 
compounds are likely to be broad-spectrum resistance modifiers considering that this was observed 
across all classes of antibiotics tested.  
 
CONCLUSION 
Strains of Staphylococcus are important pathogens causing wound infections. Most clinical isolates 
of Staphylococcus aureus are at present resistant to a number of antibiotics necessitating the search 
for alternative treatment options using medicinal plants. Extracts of Garcinia kola seeds possessed 
good antibacterial activity against clinical isolates of Staphylococcus. The combinations of the 
acetone extract of this plant with six first-line antibiotics exhibited a marginal ability to improve the 
bactericidal potency of the antibiotics. The findings of this study are significant as they demonstrate 
the potential of obtaining some valuable compounds from this plant that can be combined with 
common antibiotics in the treatment of drug resistant staphylococcal infections. It is therefore 
necessary to carry out a bioassay directed fractionation of the acetone extract so as to isolate and 
identify the compounds responsible for the antistaphylococcal as well as the enhancement of 
antibiotic activity. Such compounds could be useful in the development of new antistaphylococcal 
drugs. 
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CHAPTER 5 
In vitro evaluation of the interactions between the acetone extract of Garcinia kola seeds and 
some antibiotics 
ABSTRACT 
The effect of combinations of the acetone extract of Garcinia kola seeds and antibiotics was 
investigated by means of the fractional inhibitory concentration (FIC) indices as well as by the use of 
time-kill assays. Using the FIC indices, synergistic interactions were observed largely against Gram 
positive organisms (FIC indices of 0.52 - 0.875) with combinations against Gram negative bacteria 
mainly yielding antagonistic interactions (FIC indices of 2.0 to 5.0). The time-kill assay detected 
synergy against both Gram negative and Gram positive organisms with a ≥ 1000 times (≥ 3 Log10) 
potentiation of the bactericidal activity of tetracycline and chloramphenicol (against E. coli ATCC 
8739 and K. pneumoniae ATCC 10031) and amoxycillin and penicillin G against Staphylococcus 
aureus ATCC 6538. The observed synergy was not specific to a particular class of antibiotics 
although combinations involving erythromycin and ciprofloxacin consistently gave antagonistic or 
indifferent interactions. We conclude that the acetone extract of Garcinia kola seeds can be a 
potential source of broad spectrum resistance modifying compounds.  
Key words: Garcinia kola; antibiotic resistance; interactions; resistance modifying compounds. 
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INTRODUCTION 
The wide use of antibiotics in the treatment of bacterial infections has led to the emergence and 
spread of resistant strains. Infections due to Staphylococcus aureus are presently resistant to beta-
lactams (Cook, 1998), while Enterococcus strains are resistant to vancomycin, ampicillin, gentamycin 
and streptomycin (Montecalvo et al., 1994). Gram negative pathogens such as Salmonella species, 
Pseudomonas aeruginosa, Klebsiella pneumoniae have become multi-drug resistant (Fluit et al., 
2001).   With this emergence of resistance, most old and cheap antibiotics such as the penicillins, the 
tetracyclines and erythromycin have been rendered ineffective. The loss of clinical efficacy of such 
previously effective first-line drugs, means that treatment of infections, as a result has to be shifted to 
second-line or third-line antibiotics that are often more expensive with numerous side effects (Brook 
et al., 2000). Notwithstanding the fact that new antimicrobial agents are being developed, the past 
record of resistance development shows that resistant strains often appear a few years after the first 
clinical use of any antibiotic (Perron et al., 2005). 
In the treatment of drug resistant infections, combinations of antibiotics have often been used as this 
takes advantage of different mechanisms of action. The use of antimicrobial agents displaying 
synergy is one of the well established indications for combination antimicrobial therapy (Rybak and 
McGrath, 1996). Antimicrobial synergism occurs when two or more antibiotics, in combination exert 
an inhibitory effect that is greater than the additive effects of the individual antibiotics. Combinations 
of antimicrobials that demonstrate an in vitro synergism against infecting strains are more likely to 
result in successful therapeutic outcome. Thus, evidence of in vitro synergism could be useful in 
selecting optimal combinations of antimicrobials for the empirical therapy of serious bacterial 
infections (Hooton et al., 1984) 
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Plant extracts and plant derived compounds have long been established to possess antimicrobial 
activity. However, plant derived compounds have been seen to lack the broad spectrum and potent 
antimicrobial activity often displayed by bacterial or fungal produced antibiotics. Attempts therefore to 
find potent, nontoxic, broad-spectrum antibiotics from plants, have not yielded any good results even 
though large-scale screens have been undertaken by both pharmaceutical and biotech firms (Lewis 
and Ausubel, 2006). 
It has been hypothesized that, in addition to the production of intrinsic antimicrobial compounds, 
plants also produce multi-drug resistance (MDR) inhibitors which enhance the activity of the 
antimicrobial compounds (Stermitz et al., 2000). This hypothesis was tested by Tegos et al. (2002), 
who showed that the activity of putative plant antimicrobials against Gram positive and Gram 
negative organisms was significantly enhanced by synthetic MDR inhibitors of MDR efflux proteins. 
Those findings provided a basis to believe that plants can be potential sources of natural MDR 
inhibitors that can potentially improve the performance of antibiotics against resistant strains. 
The screening of crude plant extracts for synergistic interactions with antibiotics is expected to 
provide leads for the isolation of MDR inhibitors. The ability of crude extracts of plants to potentiate 
the activity of antibiotics has been observed by some researchers and it is anticipated to form the 
basis for the bioassay directed isolation of potential resistance modulators from plants. In a study of 
some Jordanian plants by Darwish et al. (2002), the efficacy of the antibiotics, gentamycin and 
chloramphenicol against Staphylococcus aureus were reportedly improved by the use of plant 
materials. Ahmad and Aqil (2007), also reported that crude extracts of Indian medicinal plants 
demonstrated synergistic interactions with tetracycline and ciprofloxacin against extended spectrum 
beta-lactamases (ESβL)-producing multidrug resistant enteric bacteria. Betoni et al. (2006) also 
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observed synergistic interactions between extracts of Brazilian medicinal plants and eight antibiotics 
on Staphylococcus aureus. The use of Catha edulis extracts at sub-inhibitory levels, has been 
reported to reduce the minimum inhibitory concentration (MIC) values of tetracycline and penicillin G 
against resistant oral pathogens, Streptococcus oralis, Streptococcus sanguis and Fusobacterium 
nucleatum (Al-hebshi et al., 2006). 
A number of compounds with an in vitro activity of reducing the MICs of antibiotics against resistant 
organisms have also been isolated from plants. Polyphenols (epicatechin gallate and catechin 
gallate) have been reported to reverse beta-lactam resistance in Methicillin Resistant 
Staphylococcus aureus (MRSA) (Stapleton et al., 2004). Diterpenes, triterpenes, alkyl gallates, 
flavones and pyridines have also been reported to possess resistance modulating abilities in 
combination with various antibiotics against resistant strains of Staphylococcus aureus (Marquez et 
al., 2005; Smith et al., 2007; Shibata et al., 2005 and Oluwatuyi et al., 2004). 
Garcinia kola is a plant that has shown immense potential as a source of chemotherapeutic 
compounds (Farombi et al., 2002; Han et al., 2005). The seeds of the plant, commonly known as 
bitter kola are used in West Africa for the treatment of liver disease, bronchitis, throat infections and 
in the relief of colic (Iwu et al., 1999). Many phytochemical studies have revealed that the seed is rich 
in flavonoids and other water soluble polyphenolic compounds (Iwu and Igboko, 1982; Han et al., 
2005). While the antibacterial potentials of Garcinia kola seed extracts has previously been studied, 
the interactions between the extracts of this plant and antibiotics has not been documented, 
especially with regards to its potential as a source of resistance modifying compounds.  In this paper, 
we report the effect of the acetone extract of Garcinia kola seeds on the antibacterial potencies of six 
first-line antibiotics.  
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MATERIALS AND METHODS 
Plant extract preparation 
The extracts of the seed were prepared in accordance to the description of Basri and Fan (2005). 
One hundred grams of seed powder was steeped in 500 ml of absolute acetone for 24 hours with 
shaking. The resultant extract was centrifuged at 3000 rpm for 5 minutes at 4 oC. The supernatant 
was then filtered through a Whatman No.1 filter paper while the residue was used for a second 
extraction with 300 ml of the solvent. After the second extraction, the filtrates were concentrated 
under reduced pressure using a rotary evaporator at 50 oC. The concentrated extract was then 
allowed to dry at room temperature to a constant weight. 
Preparation of bacterial inocula 
The inocula of the test organisms were prepared using the colony suspension method (EUCAST, 
2003). Colonies picked from 24 hour old cultures grown on nutrient agar were used to make 
suspension of the test organisms in saline solution to give an optical density of approximately 0.1 at 
600 nm. The suspension was then diluted 1:100 by transfer of 0.1 ml of the bacterial suspension to 
9.9 ml of sterile nutrient broth before use. 
Antibiotics used in this study 
The following antibiotics were used in this study: Penicillin G sodium (Duchefa); Amoxycillin 
(Duchefa); Chloramphenicol (Duchefa); Tetracycline hydrochloride (Duchefa); Erythromycin 
(Duchefa) and Ciprofloxacin (Fluka).  
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Determination of the Minimum Inhibitory Concentrations (MIC) 
 The minimum inhibitory concentrations of the antibiotics and plant extracts were determined using 
the standard method of the European Committee for Antimicrobial Susceptibility Testing (EUCAST, 
2000). Dilutions of the antibiotics, ranging from 0.004 – 512 mgl-1 in nutrient agar were prepared by 
incorporating the antibiotic stock solution into molten agar at 50 oC. Dilutions of the extract ranging 
from 0.039 - 20 mgml-1 were also prepared by incorporation of the extract in agar at 50 oC. After 
pouring onto plates and allowing the agar to set, the plates were inoculated with standardized inocula 
of the test bacteria by streaking in duplicates. Plates were incubated at 37 oC for 24 hours under 
aerobic conditions. The MIC was defined as the lowest concentration of the antibiotic that completely 
inhibited visible growth of the test organism as judged by the naked eye, disregarding a single colony 
or a thin haze within the area of inoculation (EUCAST, 2000). 
Combination Studies 
The checkerboard method 
The study of the combined antimicrobial activity of the plant extracts and antibiotics was done using 
the agar dilution checkerboard method as described by Mandal et al. (2004). The extract and the 
antibiotics were combined by incorporation into molten nutrient agar at concentrations ranging from 
1/8 to 2× MIC. After setting, the plates were inoculated with standardized cultures by streaking using 
a standard loop in duplicates. Plates were incubated for 24 hours at 37 °C after which the MIC values 
were estimated. The fractional inhibitory concentrations (FIC) were derived from the lowest 
concentration of antibiotic and extract combination permitting no visible growth of the test organisms 
(Mandal et al., 2004). The FIC value for each agent was calculated using the formular; 
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The interactions between the antibiotics and the extracts were evaluated by use of the FIC indices 
which were calculated using the formular; 
FIC Index = ∑FIC = FIC (antibiotic) + FIC (plant extract) 
Combinations were classified as synergistic, if the FIC indices were < 1, additive if the FIC indices 
were = 1, indifferent if the FIC indices were between 1 and 2 and antagonistic if the FIC indices were 
> 2 (Kamatou et al., 2006). Where more than one combination resulted in a change in the MIC value 
of the extract or antibiotic, the FIC value was expressed as the average of the individual FIC values 
as described by Pankey at al. (2005). 
The time-kill method 
The effects of combinations of the acetone extract of Garcinia kola seeds and antibiotics were also 
evaluated by use of the time-kill assay. This was performed by a broth macrodilution technique 
following the descriptions of White et al. (1996) and Pankey et al. (2005). The extract and antibiotics 
were incorporated into 50 ml of nutrient broth at 0.5× MIC and 1× MIC respectively. Controls 
consisting of nutrient broth incorporated with the extract and the respective antibiotic alone at the test 
concentrations were included in each experiment. 
FIC (antibiotic) =     MIC of antibiotic in combination 
  
  MIC of antibiotic alone 
FIC (extract) =      MIC of extract in combination 
  
  MIC of extract alone 
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The test and control flasks were inoculated with each test organism to a final inoculum density of 
approximately 105 cfuml-1. Immediately after inoculation, aliquots (100 µl) of the negative control 
flasks were taken, serially diluted in sterile saline and plated on nutrient agar in order to determine 
the zero hour counts. The test flasks were then incubated at 37 oC with shaking at 120 rpm. After 24 
hours of incubation, samples were taken from each test and control flasks, serially diluted in sterile 
saline and plated (100 µl) on nutrient agar in duplicates. For a better visual observation of the 
colonies in the agar, 1 ml of 0.5% aqueous solution of 2,3,5 triphenol tetrazolium chloride 
(Neugebauer and Gilliland, 2005) was added to 100 ml of molten agar before plating. 
The plates were incubated at 37 oC for 24 hours under aerobic conditions. After incubation, the 
number of colonies were enumerated and the mean counts (cfuml-1) for each test and controls were 
determined and expressed as Log10 cfuml-1.  
The interactions were considered synergistic if there was a decrease of ≥ 2 Log10 cfuml-1 after 24 
hours by the combination compared to the most active single agent (Pankey et al., 2005). Additivity 
or indifference was defined as a < 2 Log10 cfuml-1 change in average viable counts after 24 hours for 
the combination, in comparison with the most active single agent. Antagonism was defined as a ≥ 2 
Log10 cfuml-1 increase in colony counts after 24 hours by the combination compared with that by the 
most active single agent (Pankey et al., 2005; Lee et al., 2006). 
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RESULTS 
The MIC values of the antibiotics used in this study are shown in Table 1. Susceptibility to beta-
lactam antibiotics, amoxycillin and penicillin G was higher against Gram positive organisms (MIC 
ranges of 0.015 – 0.25 mgl-1) than against Gram negatives (MIC ranges of 2 – 32 mgl-1). The 
macrolide, erythromycin had the highest MIC values of 128 mgl-1 against E. coli ATCC 8739 and 512 
mgl-1 against Proteus vulgaris and Enterococcus faecalis. Gram negative organisms exhibited higher 
susceptibility to ciprofloxacin (MIC ranges of 0.015 – 0.25mgl-1) than other antibiotics. 
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Table 1: MIC values for antibiotics. 
Test Isolate  MIC Values (mgl-1) 
 
Amx PenG Tet Chlo Ery Cip 
Staph. aureus ATCC 6538 0.015 0.008 0.25 2 0.25 0.5 
Str. faecalis ATCC 29212 0.5 1 8 4 0.5 0.5 
Ent. faecalis 0.25 8 32 64 512 0.5 
E. coli ATCC 8739 4 32 1 4 128 0.312 
 
K. pneumoniae ATCC 10031 32 64 0.5 1 4 0.015 
P. vulgaris CSIR 0030 2 32 16 8 512 0.25 
 
      
 
Key: Amx - Amoxycillin; PenG - Penicillin G; Tet - Tetracycline; Chlo - Chloramphenicol; Ery - Erythromycin; 
Cip - Ciprofloxacin 
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The FIC values of the acetone extract and the antibiotics, amoxycillin, ciprofloxacin, tetracycline and 
chloramphenicol are shown in Table 2. The activity of the antibiotics against Gram negative 
organisms was largely reduced by the presence of sub-inhibitory concentrations of the extract. The 
FIC indices for most of the combinations against Gram positive organisms ranged from 0.52 – 1.00 
with only Enterococcus faecalis having an FIC index of 1.625 in the combination involving 
amoxycillin. The activity of all the antibiotics against Klebsiella pneumoniae ATCC 10031, was 
reduced by the presence of the extract with FIC indices for ciprofloxacin, chloramphenicol and 
tetracycline ranging from 2.00 – 5.00. The nucleic acid inhibitor, ciprofloxacin showed lack of synergy 
with the plant extract against all but one of the test organisms (Streptococcus faecalis ATCC 29212). 
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Table 2: Fractional inhibitory Concentration (FIC) values and indices for the combinations of the acetone 
extract of G. kola and antibiotics. 
Antibiotic  Test isolate 
Mean FIC 
(Antibiotic) 
Mean FIC 
(Extract) 
FIC 
Index Interaction 
Amoxycillin Staph. aureus ATCC 6538 0.196 0.5 0.52 Synergy 
 
Str. faecalis ATCC 29212 0.5 0.5 1.00 Additivity 
 
Ent. faecalis 1.25 0.375 1.625 Indifference 
Ciprofloxacin Str. faecalis ATCC 29212 0.375 0.25 0.625 Synergy 
 
Ent. faecalis 0.375 0.5 0.875 Synergy 
 
E. coli ATCC 8739 2.00 0.06 2.06 Antagonism 
 
K. pneumoniae ATCC 10031 4.00 0.06 4.06 Antagonism 
Chloramphenicol Str. faecalis ATCC 29212 0.375 0.5 0.875 Synergy 
 
Ent. faecalis 0.234 0.5 0.734 Synergy 
 
E. coli ATCC 8739 0.5 0.25 0.75 Synergy 
 
K. pneumoniae ATCC 10031 1.00 1.00 2.00 Antagonism 
Tetracycline Str. faecalis ATCC 29212 0.375 0.5 0.875 Synergy 
 
Ent. faecalis 0.3125 0.374 0.686 Synergy 
 
K. pneumoniae ATCC 10031 4.00 1.00 5.00 Antagonism 
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The time-kill effect of combinations of the acetone extract of Garcinia kola and antibiotics is shown in 
Table 3. The extract showed ability to improve the bactericidal effect of beta-lactam antibiotics on 
Gram positive organisms. The bactericidal activity of amoxycillin and penicillin G was increased by 
5.15 and 3.27 Log10 bases respectively against Staphylococcus aureus ATCC 6538. Marginal 
improvement (less than 2 Log10 bases potentiation) in the activity of amoxycillin against 
Streptococcus faecalis ATCC 29212 and Enterococcus faecalis was also observed. The bacterial 
killing activity of protein synthesis inhibitors, tetracycline and chloramphenicol was also increased 
against both Gram positive and Gram negative organisms with the bactericidal effect of tetracycline 
showing broad spectrum activity. Erythromycin was strongly potentiated against Gram positive 
organisms Staphylococcus aureus ATCC 6538 and Streptococcus faecalis ATCC 29212 but the 
activity of the same antibiotic was severely reduced against Gram negative bacteria, E. coli ATCC 
8739 and Klebsiella pneumoniae ATCC 10031. 
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Table 3: The effect of combinations of the acetone extract of Garcinia kola seeds and antibiotics determined by 
the time-kill assay 
 
Changes in bacterial counts (Log10 cfuml-1 ) for the combination 
compared with the two agents used alone 
Test Organism Amx PenG Chlo Tet Ery Cip 
Staph.  aureus ATCC 6538 
 
 
 
 
-5.15 (S) 
 
 
 
 
-3.27 (S) 
 
 
 
 
-1.04 (I) 
 
 
 
 
-3.24 (S) 
 
 
 
 
-2.44 (S) 
 
 
 
 
0.00 (I) 
Str. faecalis ATCC 29212 
 
 
 
-0.88 (I) 
 
 
 
0.69 (I) 
 
 
 
-1.15 (I) 
 
 
 
-1.46 (I) 
 
 
 
-2.02 (S) 
 
 
 
-2.96 (S) 
Ent. faecalis -1.79 (I) 0.63 (I) 0.003 (I) -0.37 (I) -0.21 (I) 0.33 (I) 
E. coli ATCC 8739 0.59 (I) -2.78 (S) -3.28 (S) -5.94 (S) 2.73 (A) 4.18 (A) 
K. pneumoniae ATCC 10031 1.03 (I) -0.47 (I) -3.21(S) -3.34 (S) 4.78 (A) 5.06 (A) 
P. vulgaris CSIR 0030 3.72 (A) 3.54 (A) 2.56 (A) -0.73 (I) -0.02 (I) 0.10 (I) 
 
      
 
Key: Amx- Amoxycillin; PenG- Penicillin G; Tet-Tetracycline; Chlo- Chloramphenicol; Ery- Erythromycin; Cip- 
Ciprofloxacin (S) - Synergy; (I) - Indifference/Additivity; (A) - Antagonism 
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DISCUSSION 
The organisms used in this study were reference as well as environmental strains of pathogenic 
organisms often posing problems of drug resistance in clinical settings. In order to assess the effects 
of combinations of the extracts of the plant and antibiotics, the MIC values of the antibiotics had to be 
determined as these provided the reference point for defining the interactions. The objective of 
testing plant extracts for potentials of synergy with antibiotics is to assess if combinations of such 
extracts with antibiotics can bring about positive changes in the susceptibility of the test strains, thus 
necessitating the use of strains resistant to the test antibiotics. For that reason therefore, the British 
Society for Antimicrobial Chemotherapy (BSAC) and EUCAST (2005), recommended MIC 
breakpoints were used as a way of determining the presence or lack of resistance in the test isolates. 
Although this data is often used in surveillance studies to monitor trends in resistance development, 
we saw it convenient to apply it in our studies in the absence of a standard.   
 According to the MIC breakpoints, strains of Staphylococcus and Streptococcus with MIC values of 
≥ 0.25 mgl-1 (for penicillin G), ≥ 2 mgl-1 (for amoxycillin), ≥ 2 mgl-1 (for tetracycline), ≥ 1 mgl-1 (for 
erythromycin), ≥ 4 mgl-1 (for chloramphenicol) and ≥ 1 mgl-1 (for ciprofloxacin) are classified as 
resistant. From our results, Streptococcus faecalis ATCC 29212 and Enterococcus faecalis were 
resistant to penicillin G, tetracycline, chloramphenicol, and erythromycin. The MIC values for these 
organisms ranged from 4 to 512 times higher than the predicted breakpoint values. The breakpoint 
values for enteric bacteria are; 16 mgl-1 (penicillins), 2 mgl-1 (tetracycline), 16 mgl-1 (chloramphenicol) 
and 1 mgl-1 (ciprofloxacin) (BSAC and EUCAST, 2005). The enteric bacteria used in this study 
showed varying levels of susceptibility to the test antibiotics. Klebsiella pneumoniae ATCC 10031 
exhibited low susceptibility to both penicillin G and amoxycillin while E. coli ATCC 8739 and Proteus 
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vulgaris CSIR 0030 were more susceptible to amoxycillin. The enteric organisms were generally 
susceptible to chloramphenicol and ciprofloxacin but had high MIC values against erythromycin. The 
presence of such elevated MIC values for some of the organisms used in this study against such 
common front-line antibiotics may reflect a common presence of resistance mechanisms universally 
present in bacteria, and may justify the need to seek strategies to inhibit such mechanisms. 
Combinations of antibiotics and the acetone extract of Garcinia kola seeds were investigated for 
possible synergistic interactions. In the checkerboard method, synergy is based on the increased 
susceptibility of the test organism to the presence of both antimicrobial agents which is reflected by 
changes in the MIC values (Odds, 2003). Using the FIC indices, synergy was detected mainly 
against Gram positive organisms. The synergy against Streptococcus faecalis ATCC 29212 and 
Enterococcus faecalis is an important observation as these organisms were resistant to penicillin G, 
tetracycline, chloramphenicol, and erythromycin with MIC values much higher than their predicted 
breakpoints. Although the level of antibiotic potentiation was low (FIC Indices of 0.52 - 1.00) as not to 
lead to a restoration of susceptibility (lowering the MIC values to below the breakpoint values) the 
results seem promising considering that crude extracts were used. The potentiation is likely to have 
been much more pronounced had purified compounds been used. Since the synergy was not 
specific to any class of antibiotics, it is likely that the target for this interaction could be cell 
membrane since it is the fundamental difference between Gram negative and Gram positive bacteria.  
As an alternative method, the time-kill assay was also employed to assess the effect of the 
combinations. This method is based on a comparison of the killing rate of the combination to that of 
the individual agents. In the experiment, the extract was incorporated at sub-inhibitory concentrations 
(1/2× MIC) with the antibiotic used at the minimum inhibitory concentration.  
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In contrast to the checkerboard method, the time-kill assay detected synergy against both Gram 
positive and Gram negative organisms. Strong synergistic interactions on Staphylococcus aureus 
ATCC 6538 were observed in combinations involving beta-lactams (amoxycillin and penicillin G) as 
well as the protein synthesis inhibitors, tetracycline and erythromycin. Combinations involving 
tetracycline and chloramphenicol were highly bactericidal against E. coli ATCC8 7339 and K. 
pneumoniae ATCC 10031 with a more than 1000 fold (> 3 Log10) potentiation of the antibiotic (Table 
3). Combinations involving erythromycin and ciprofloxacin against the same Gram negative 
organisms were largely antagonistic. 
The synergy detected by the time-kill assay was not specific to any group of organisms or class of 
antibiotics. This suggests that the crude extracts of this plant could be containing a mixture of 
compounds that can enhance the activity of different antibiotics. The seeds of Garcinia kola have 
been known to contain a number of antimicrobial compounds (Iwu et al., 1999) such as polyphenols 
and flavonoids. The antimicrobial and resistance modifying potentials of some naturally occurring 
flavonoids and polyphenolic compounds have been reported by other studies (Cushnie and Lamb, 
2005; Sato et al., 2004). This would suggest that, the synergy with antibiotics observed in this study 
could be attributable to such compounds.  Some of these compounds like polyphenols have been 
shown to exert their antibacterial action through membrane perturbations. This perturbation of the 
cell membrane coupled with the action of beta-lactams on the transpeptidation of the cell membrane 
could lead to an enhanced antimicrobial effect of the combination (Esimone et al., 2006). It has also 
been shown that some plant derived compounds can improve the in vitro activity of some 
peptidoglycan inhibiting antibiotics by directly attacking the same site (i.e. peptidoglycan) in the cell 
wall (Zhao et al., 2001).  
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While the above explanations may account for the synergy between the extracts and beta-lactam 
antibiotics that act on the cell wall, it might not apply in the case of the observed synergy with other 
classes of antibiotics with different targets such as tetracycline, erythromycin, ciprofloxacin and 
chloramphenicol. Bacterial efflux pumps are responsible for a significant level of resistance to 
antibiotics in pathogenic bacteria (Kumar and Schweizer, 2005). Some plant derived compounds 
have been observed to enhance the activity of antimicrobial compounds by inhibiting MDR efflux 
systems in bacteria (Tegos et al., 2002). 5’-methoxyhydnocarpin is an example of an inhibitor of the 
NorA efflux pump of Staphylococcus aureus isolated from Berberis fremontii (Stermitz et al., 2000). It 
is likely that the acetone extract of Garcinia kola seeds could be containing potential MDR efflux 
pump inhibitors. Such compounds are likely to be broad spectrum efflux inhibitors considering that 
the synergistic effect of the extract was observed on both Gram positive and Gram negative 
organisms as well as in combination with, cell wall inhibiting and protein synthesis inhibiting 
antibiotics. In fact, some broad spectrum efflux pump inhibitors have been isolated from some plants. 
Smith et al. (2007) reported one efflux pump inhibitor (ferruginol) from the cones of Chamaecyparis 
lawsoniana that inhibited the activity of the quinolone resistance pump (NorA), the tetracycline 
resistance pump, (TetK) and the erythromycin resistance pump, (MsrA) in Staphylococcus aureus. 
The strong synergy observed between the extracts of Garcinia kola and common first-line antibiotics 
is a significant finding demonstrating the therapeutic potentials of this plant. However, there is a need 
to establish the molecular basis of these interactions.  
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CONCLUSION 
The extracts of Garcinia kola seeds showed potentials of synergy in combination with some 
antibiotics against reference strains of pathogenic organisms often posing problems of drug 
resistance. The detection of synergy between crude extract of Garcinia kola and antibiotics 
demonstrates the potential of this plant as a source of antibiotic resistance modifying compounds. It 
is necessary to carry out a bioassay guided fractionation of the acetone extract of this plant in a bid 
to isolate and identify the compounds responsible for the enhancement of antibiotic activity. An 
elucidation of the mechanisms of action of these compounds must be followed by toxicity and in vivo 
tests to determine the therapeutic application of such compounds in combination therapy. These are 
subjects of on-going investigation in our research group.  
 
ACKNOWLEDGEMENT 
The authors are grateful to the National Research Foundation (NRF) of the Republic of South Africa 
for financial support. 
 
 
 
 
 
119 
 
REFERENCES 
Ahmad I, and Aqil F (2007). In vitro efficacy of bioactive extracts of 15 medicinal plants against 
ESβL-producing multidrug-resistant enteric bacteria. Micro. Res.162: 264-275. 
Al-hebshi N, Al-haroni M, and Skaug N (2006). In vitro antimicrobial and resistance-modifying 
activities of aqueous crude khat extracts against oral microorganisms. Arch Oral Biol. 51: 183-
188. 
Basri DF, and Fan SH (2005). The potential of aqueous and acetone extracts of galls of Queercus 
infectoria as antibacterial agents. Ind. J. Pharm. 37: 26-29. 
Betoni JEC, Mantovani RP, Barbosa LN, Di-Stasi LC, and Fernandes A (2006). Synergism between 
plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem. Inst. 
Oswaldo Cruz. 101 no.4. 
Brook I, Gooch WM, Jenkins SG, Pichichero ME, Reiner SA, Sher L, and Yamauchi T (2000). 
Medical management of acute bacterial sinusitis: Recommendations of a clinical advisory 
committee on pediatric and adult sinusitis. Ann. Otol. Rhinol. Laryngol. 109: 1-19. 
British Society for antimicrobial Chemotherapy (BSAC) and European Committee for Antimicrobial 
Susceptibility Testing (EUCAST) (2005). Establishing MIC breakpoints and the interpretation of 
in vitro susceptibility tests:  1-21.  
Cook N (1998). Methicillin resistant Staphylococcus aureus versus the burn patient. Burns 24: 91-98. 
Cushnie TPT, and Lamb AJ (2005). Antimicrobial activity of flavonoids. Int. J. Antimic. Agents. 26(5): 
343-356. 
120 
 
Darwish RM, Aburjai T, Al-Khalil S, and Mahafzah A (2002). Screening of antibiotic resistant 
inhibitors from local plant materials against two different strains of Staphylococcus aureus. J. 
Ethnopharm. 79: 359-364. 
Esimone CO, Iroha IR, Ibezim EC, Okeh CO, and Okpana EM (2006). In vitro evaluation of the 
interaction between tea extracts and penicillin G against Staphylococcus aureus. Afr. J. 
Biotech. 5(11): 1082-1086. 
European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2003). Determination of 
minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. 
Micro. Inf. 9(8): 1-7. 
European Committtee for Antimicrobial Susceptibity Testing (EUCAST) (2000). Determination of 
minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin. 
Micro. Inf. 6(9): 509-515.  
Farombi EO, Alabi MC, and Akuru TO (2002). Kolaviron modulates cellular redox status and 
impairment of membrane protein activities induced by potassium bromate (KBrO3) in rats. 
Pharmacol. Res. 45(1): 63-68. 
Fluit AC, Schmitz FJ, Verhoef J, and European SENTRY Participants (2001). Multi-resistance to 
antimicrobial agents for the ten most frequently isolated bacterial pathogens. Int. J. Antimic. 
Agents 18: 147-160. 
Han QB, Lee SF, Qiao CF, He ZD, Song JZ, Sun HD, and Xu HX (2005). Complete NMR 
assignments of the antibacterial biflavonoid GB1 from Garcinia kola. Chem. Pharm. Bull. 53(8): 
1034-1036. 
121 
 
Hooton TM, Blair AD, Turck M, and Counts GW (1984). Synergism at clinically attainable 
concentrations of aminoglycoside and beta-lactam antibiotics. Antimic. Agents Chemo. 26(4): 
535-538. 
Iwu M, and Igboko O (1982). Flavonoids of Garcinia kola seeds. J. Nat. Prod. 650-650. 
Iwu MW, Duncan AR, and Okunji CO (1999). New antimicrobials of plant origin. J. Janick (ed.), 
Perspectives on new crops and new uses: 457-462. 
Kamatou GPP, Viljoen AM, van Vuuren SF, and van Zyl RL (2006). In vitro evidence of antimicrobial 
synergy between Salvia chamelaeagnea and Leonotis leonurus. SA J. Bot. 72: 634-636. 
Kumar A, and Schweizer HP (2005). Bacterial resistance to antibiotics: Active efflux and reduced 
uptake. Adv. Drug Deliv. Revs. 57: 1486-1513. 
Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, and Song JH (2006). Synergy 
of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus 
aureus. J. Korean Med Sci. 21: 188-92. 
Lewis K, and Ausubel FM (2006). Prospects for plant-derived antibacterials. Nature Biotech. 24(12): 
1504-1507. 
Mandal S, Mandal MD, and Pal NK (2004). Evaluation of combination effect of ciprofloxacin and 
cefazolin against Salmonella enterica serovar typhi isolates by in vitro methods. Calicut 
Med. J. 2(2): e2. 
Marquez B, Neuville L, Moreau NJ, Genet JP, Santos AF, Andrade MCC, and Sant’Ana AEG (2005). 
Multidrug resistance reversal agent from Jatropha elliptica. Phytochem. 66: 1804-1811. 
122 
 
Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, and Wormser 
GP (1994). Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus 
faecium bacteremia in an adult oncology unit.  Antimic. Agents Chemo. 38(6): 1363-1367. 
Neugebauer KA, and Gilliland SE (2005). Antagonistic action of Lactobacillus delbrueckii ssp. lactis 
RM2-5 toward spoilage organisms in cottage cheese. J. Dairy Sci. 88: 1335-1341. 
Odds FC (2003). Synergy, antagonism, and what the chequerboard puts between them. J. Antimic. 
Chemo. 52(1): 1-1. 
Oluwatuyi M, Kaatz GW, and Gibbons S (2004). Antibacterial and resistance modifying activity of 
Rosmarinus officinalis. Phytochem. 65(24): 3249-3254. 
Pankey G, Ashcraft D, and Patel N (2005). In vitro synergy of daptomycin plus rifampin against 
Enterococcus faecium resistant to both linezolid and vancomycin. Antimic. Agents Chemo. 
49(12): 5166-5168. 
Perron GG, Zasloff M, and Bell G (2005). Experimental evolution of resistance to an antimicrobial 
peptide. Proc. Biol. Sci. 273(1583): 251-256. 
Rybak MJ, and McGrath BJ (1996). Combination antimicrobial therapy for bacterial infections. 
Guidelines for the clinician. Drugs. 52(3): 390-405. 
Sato Y, Shibata H, Arai T, Yamamoto A, Okimura Y, Arakaki N, and Higuti T (2004). Variation in 
synergistic activity by flavone and its related compounds on the increased susceptibility of 
various strains of methicillin-resistant Staphylococcus aureus to β-lactam antibiotics. Int. J. 
Antimic.  Agents. 24(3): 226-233. 
123 
 
Shibata H, Kondo K, Katsuyama R, Kawazoe K, Sato Y, Murakami K, Takaishi Y, Arakaki N, and 
Higuti T (2005). Alkyl gallates, intensifiers of β-lactam susceptibility in methicillin-resistant 
Staphylococcus aureus   Antimic. Agents Chemo. 49(2): 549-555. 
Smith ECJ, Williamson EM, Wareham N, Kaatz GW, and Gibbons S (2007). Antibacterials and 
modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. 
Phytochem. 68(2): 210-217. 
Stapleton PD, Shah S, Anderson JC, Hara Y, Hamilton-Miller JMT, and Taylor PW (2004). 
Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. 
Antimic. Agents. 23(5): 462-467. 
Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, and Lewis K (2000). Synergy in a medicinal plant: 
Antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump 
inhibitor. Appl. Biol.  Sci. 97(4): 1433-1437. 
Tegos G, Stermitz FR, Lomovskaya O, and Lewis K (2002). Multidrug pump inhibitors uncover 
remarkable activity of plant antimicrobials. Antimic. Agents Chemo. 46(10): 3133-3141. 
White RL, Burgess DS, Manduru M, and Bosso JA (1996). Comparison of three different in vitro 
methods of detecting synergy: Time-Kill, Checkerboard, and E test. Antimic. Agents Chemo. 
40(8): 1914-1918. 
Zhao WH, Hu ZQ, Okubo S, Hara Y, and Shimamura T (2001). Mechanism of synergy between 
epigallochatechin gallate and β-lactams against methicillin resistant Staphylococcus aureus. 
124 
 
CHAPTER 6 
GENERAL DISCUSSION AND CONCLUSION 
Resistance to antibiotics by major bacterial pathogens has limited the efficacy of current antibacterial   
drugs. This has necessitated the search for new alternative compounds. In addition, the combined 
use of antibiotics and compounds that inhibit resistance mechanisms allowing the antibiotic to regain 
its potency against resistant pathogens has also been seen as an alternative approach to mitigate 
the effect of resistance among bacterial pathogens. 
Medicinal plants, owing to their rich diversity of secondary metabolites, promise to provide a potential 
source of these two types of compounds, if the rich chemical diversity could be adequately tapped. A 
number of plant derived compounds have been reported to exhibit in vitro synergy with antibiotics 
against resistant strains of pathogenic bacteria. The synergy has been reported in a few cases, to 
involve dual targeting or mutual interference between the plant compounds and antibiotics (Zhao et 
al., 2001; Yam et al., 1998). To a greater extent, however, the synergy has been attributed to 
inhibition of antibiotic MDR efflux proteins (Smith et al., 2007; Marquez et al., 2005; Oluwatuyi et al., 
2004). It is the prospects of obtaining potent broad spectrum MDR efflux pump inhibitors from plants 
that has been considered attractive (Lomovskaya and Bostain, 2006; Lewis and Ausubel, 2006). 
Obtaining drug preparations based on combinations between efflux pump inhibitors and antibiotics 
can help to recover the clinical efficacy of old antibiotics that have been rendered ineffective due to 
resistance.   
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In this report, seed extracts of Garcinia kola, a tropical plant of the family Guttiferae which is widely 
distributed in West and Central Africa where it is valued for its medicinal properties, were assessed 
for their antimicrobial properties as well as the potentials of their combinations with antibiotics.   
In the antibacterial activity assays, the aqueous and acetone extracts of the seed were evaluated for 
their activity against 27 bacterial strains. The aqueous extract showed activity mainly against Gram 
positive organisms with MIC values ranging from 5 – 20 mgml-1 while the acetone extract exhibited 
activity against both Gram negative and Gram positive organisms with MIC values ranging from 
0.156 - 10 mgml-1. The bactericidal activity of the acetone extract revealed that the extract was 
strongly bactericidal against Staphylococcus aureus and Proteus vulgaris at concentrations of 0.3125 
and 5 mgml-1 respectively. 
In the antistaphylococcal activity assay, the aqueous, methanol and acetone extracts of the seeds 
were investigated for their activity against four clinical strains of Staphylococcus obtained from cases 
of wound sepsis. All the strains were susceptible to the aqueous extract at 30 mgml-1 with MIC 
values of 10 mgml-1. The methanol and acetone extracts exhibited more potency with the strains 
susceptible at 10mgml-1 and MIC values ranging from 0.312 to 0.625 mgml-1. The bactericidal activity 
of the acetone extract revealed that the extract was strongly bactericidal against one of the isolates 
(OKOH3) but weakly bactericidal against another isolate (OKOH1). 
In the study of the effect of combinations between the extracts of the plant and antibiotics,  
combinations of the acetone extract and the antibiotics penicillin G, amoxycillin, tetracycline, 
chloramphenicol, erythromycin and ciprofloxacin were investigated by means of the fractional 
inhibitory concentration (FIC) indices as well as by the use of time-kill assays. Synergistic 
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interactions with some antibiotics were observed largely against Gram positive organisms using the 
FIC indices, with combinations against Gram negative organisms yielding largely antagonistic 
interactions. The time-kill assay detected synergy involving all antibiotics against both Gram negative 
and Gram positive organisms with a ≥ 1000 times (≥ 3 Log10) potentiation of the bactericidal activity 
for some antibiotics.  
In total, the results of this research unveiled some significant findings on the therapeutic potentials of 
the seeds of Garcinia kola laying a foundation for possible future studies that may lead to the 
production of some chemotherapeutically useful compounds. Considering these significant findings, 
this research therefore concludes with the following recommendations: 
• There is need to widen the extractant variability in the antibacterial activity of the plant since 
the activity of the plant will depend on the properties of the extracting solvent used. Notably 
solvents such as chloroform, dichloromethane, hexane among others have not been 
previously investigated. 
• There is need to investigate the bactericidal potency of the plant against a wider range of 
clinical isolates of pathogenic organisms in order to obtain a more accurate evaluation of the 
plant’s therapeutic potential. 
• There is also need to carry out a bioassay guided fractionation of the acetone extract of the 
plant in a bid to isolate the compounds responsible for the antibacterial as well as the 
potentiation of antibiotic activity. Further, it will be necessary to elucidate the mechanism of 
action of such compounds as well as their levels of toxicity to assess their clinical 
applicability.  
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